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ABSTRACT 
 
 
Despite recent advances in our understanding of biochemical regulation of 
neutrophil chemotaxis, little is known about how mechanical factors control neutrophils’ 
persistent polarity and rapid motility. Here, by using a human neutrophil-like cell line and 
human primary neutrophils, we describe a dynamic spatiotemporal pattern of tractions in 
neutrophils during chemotaxis. Tractions are located at both the leading and the trailing 
edge of neutrophils, where they oscillate with a defined periodicity. Interestingly, traction 
oscillations at the leading and the trailing edge are out of phase with the tractions at the 
front leading those at the back, suggesting a temporal mechanism that coordinates leading 
edge and trailing edge activities. The magnitude and periodicity of tractions depend upon 
the activity of non-muscle myosin IIA. Specifically, traction development at the leading 
edge requires myosin light chain kinase (MLCK)-mediated myosin II contractility and is 
necessary for α5β1-integrin activation and leading edge adhesion. Localized myosin II 
activation induced by spatially activated small GTPase Rho and its downstream kinase 
p160-ROCK, as previously reported, leads to contraction of actin-myosin II complexes at 
the trailing edge, causing it to de-adhere. Our data identify a key biomechanical 
mechanism for persistent cell polarity and motility. 
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CHAPTER 1 
 
INTRODUCTION 
 
Cell migration is a fundamental process associated with various biological and 
pathophysiological phenomena. Cell migration is conceptualized as a multi-step, cyclic 
process and can be broadly classified into two categories, i.e., mesenchymal and 
amoeboid migration. It is the latter category that neutrophil chemotaxis falls under.    
Chemotaxis – the directed movement of cells in a gradient of chemoattractant – is 
essential for neutrophils to crawl to sites of inflammation and infection. Chemoattractant-
induced activation of spatially localized cellular signals causes neutrophils to initiate 
polymerization of actin at the leading edge (pseudopod), polarize (i.e., adopt an 
asymmetric shape with defined front and back) and move towards the highest 
concentration of the chemoattractant. Recent studies have begun to reveal some 
fascinating details of the intracellular biochemical components that spatially direct the 
neutrophils’ cytoskeleton and the complex signaling pathways that control formation of 
their front and back. 
Despite these findings, there are significant gaps in our understanding of the 
mechanical functions that control the persistent and rapid movement of neutrophils. 
Specifically, there is limited documentation of quantitative analysis of tractions in 
neutrophils, and the spatial and temporal dynamics, regulation and functions of tractions 
remain largely undefined.  
 
Cell migration is a multi-step, cyclic process 
Cell migration is a universal process that most cells in the body undergo at a 
given time and tissue space (Friedl, 2004). Therefore, it is widely involved in numerous 
biological as well as pathophysiological processes such as embryonic morphogenesis, 
tissue repair and regeneration, disease progression in cancer, mental retardation, and 
arthritis (Ridley et al., 2003). In general, cell migration is conceptualized as a multi-step, 
cyclic process. Initially, a cell will respond to a migration-promoting agent by polarizing 
and extending protrusions in the direction of migration. These protrusions are usually 
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driven by actin polymerization, can take a form of large, broad lamellipodia or small, 
spiky filopodia, and are stabilized by adhering to the extracellular matrix (ECM) or 
adjacent cells via transmembrane proteins linked to actin cytoskeleton (adhesion). These 
adhesions provide traction for migration as the cell propels its cytoplasmic body over 
them, and they are disassembled (de-adhesion) at the cell rear, leading to detachment (tail 
retraction). A migration cycle is completed at this point. The cell initiates another cycle 
of migration with protrusion, followed again by adhesion, de-adhesion and tail retraction, 
and repeats this multi-step process until it arrives at its target location.       
 
Mesenchymal and amoeboid migration 
While many aspects of migration are shared among different cell types, the details 
can be greatly varied. As of present, a single cell migration (as opposed to collective cell 
migration) is broadly classified into two modes, that is, mesenchymal migration and 
amoeboid migration. In the following, I discuss the distinct features of two such modes of 
migration.      
Slow-moving mesenchymal cells such as fibroblasts, myoblasts, single 
endothelial cells, and sarcoma cells exhibit distinct steps in the migration cycle as 
described in the previous section. Mesenchymal cells typically adopt a spindle-shaped, 
elongated morphology (Grinnell, 1994; Tamariz and Grinnell, 2002), which is dependent 
upon integrin-mediated adhesion dynamics and the presence of high traction forces on 
both cell poles (Ballestrem et al., 2001; Tamariz and Grinnell, 2002). Blocking integrins 
in fibroblasts, endothelial cells or tumor cells with antibody or small-molecule inhibitors 
induces cell retraction, acquisition of spherical shape and impaired migration (Friedl, 
2004). Concomitant to integrin and actin focalization at substrate-binding sites (termed 
focal adhesions or focal contacts), mesenchymal cells recruit surface proteases to digest 
and remodel the ECM (Wolf et al., 2003a). Focal contact formation and turnover occur in 
the timescale of 10~120 minutes, resulting in relatively slow migration velocities (0.1-2 
μm/min) (Ballestrem et al., 2001; Peter Friedl, 1998; W. Matthew Petroll, 2003; Zamir et 
al., 2000). 
In contrast, in fast-crawling amoeboid cells, such as neutrophils or more primitive 
Dictyostelium discoideum, steps in the migration cycle are less obvious: these cells seem 
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to glide over the substratum. In response to migration-promoting agents, amoeboid cells 
rapidly adopt a highly polarized shape, which is generated by cortical filamentous actin 
that mediates cell dynamics as well as providing stiffness to the cell body. Also, other 
amoeboid cells, including T lymphocytes and some metastatic tumor cells, usually use 
protease-independent physical mechanisms to overcome matrix barriers including 
adaptation of the cell-shape change to preformed matrix structures and squeezing through 
narrow spaces (Wolf et al., 2003b). Interestingly, unlike mesenchymal cells, no stable 
focal contacts (and stress fibers) are detected within leukocytes, whereas fast and non-
focalized receptor assemblies at cell-substrate interactions are retained (Peter Friedl, 
1998; Wolf et al., 2003b). This lack of stable focal contacts and proteolysis is thought to 
allow these cells to turn over membrane rapidly and move at high velocities (2-30 
μm/min) (Peter Friedl, 1998). 
 
Neutrophil chemotaxis is an important mechanism of an innate immune 
system against invading pathogens 
Polymorphonuclear neutrophils (PMN) are one of the first cells to reach the site 
of bacterial or viral infection and thus provide a critical first line of defense in the 
immune system against invading pathogens. At the same time, neutrophil-mediated tissue 
injuries in a number of inflammatory or autoimmune diseases such as acute respiratory 
distress syndrome (ARDS), post ischemic injury and arthritis can be detrimental. 
Therefore, more thorough understanding of mechanism of neutrophil chmotaxis is 
important as it may not only expand our knowledge of cell migration in general, but also 
facilitate development of therapeutic technologies against such diseases.   
Upon infection or inflammation, neutrophils circulating in the bloodstream are 
recruited to the injured tissue in a coordinated series of steps, which are, broadly speaking, 
capturing (tethering), rolling, arrest, crawling, transendothelial migration and interstitial 
migration (Zarbock and Ley, 2009). Neutrophils are first ‘captured’ by the inflamed 
blood endothelium, the process mediated by selectins and their counter-receptors 
expressed on both cell types (Kansas, 1996). Captured neutrophils start to ‘roll’ on the 
endothelium through the action of selectins and integrins. As neutrophils encounter 
chemoattractants presented on the endothelial cell surface, cells become ‘arrested’ by the 
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strengthening of the intercellular adhesion between neutrophils and endothelium. At this 
point, neutrophils adopt a highly polarized fan-shaped morphology and begin to crawl on 
the endothelium. Cells eventually exit the blood vessels, crawling through an 
endothelium (transendothelial migration) and continuing to migrate through an 
interstitium to the target location (interstitial migration).    
 
Biochemical signaling pathways underlying neutrophil polarity 
Chemotaxis is defined as a directed movement up a gradient of chemoattractant. 
Strictly adhering to such definition, neutrophil chemotaxis would be further limited to the 
steps following the arrest in the aforementioned neutrophil recruitment cascade, namely 
crawling, transendothelial migration and interstitial migration, as these steps directly 
involve interpretation of external chemical gradient by cells. To avoid confusion in the 
discussion hereafter, I refer to the crawling of neutrophils on a two-dimensional surface 
as neutrophil chemotaxis, unless noted otherwise.     
One striking feature of neutrophil chemotaxis is the ability of cells to interpret 
shallow gradients of external attractant to generate morphological polarity. In fact, it is a 
characteristic shared by most chemotactic cells, including Dictyostelium discoideum and 
fibroblasts, albeit with different degrees. In particular, upon exposure to chemoattractants, 
amoeboid neutrophils rapidly adopt a polarized morphology in which filamentous actin 
(F-actin) is predominantly recruited to the leading edge. In addition, actomyosin 
contractile complexes are found both at the leading edge and trailing edge in neutrophils, 
with the majority of complexes localized at the trailing edge. Such spatial segregation of 
distinct actin assemblies is thought to account for morphological polarity of neutrophils, 
in which propulsion of F-actin against the plasma membrane at the leading edge leads to 
a broad front, whereas contraction of actomyosin complexes at the trailing edge results in 
a narrow back. Surprisingly, a gradient of chemoattractant is not necessary for 
neutrophils to polarize: in uniform concentration of chemoattractant, neutrophils can 
polarize, albeit in random directions and with reduced persistency.  
How do neutrophils polarize? Studies on primary human neutrophils mostly relied 
on pharmacological inhibitors due to two properties of these cells; they are terminally 
differentiated cells and die within 24 hrs after isolation from the blood, and are refractory 
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to transfection. Such challenges in studying human neutrophils have been overcome 
recently by the development of a culture model of human neutrophils. HL-60 is a cell line 
derived from promyelocytic leukemia cells which can be differentiated by DMSO to have 
neutrophil-like properties and are genetically tractable (Hauert et al., 2002). With this 
model system, the following model of biochemical signaling pathways underlying 
polarity of human neutrophils emerged.  
 
A frontness signaling pathway involving positive feedback loop of PI3K, Rac, and F-actin  
The first step toward understanding signals involved in the positive feedback loop 
was the demonstration that phosphatidylinositol-3,4,5-tri-phosphate (PI[3,4,5]P3) and 
other products of phophoinositide-3’-kinase (PI3Ks) accumulate selectively in 
membranes of the moving cell’s leading edge in Dictyostelium (Meili and Firtel, 2003; 
Parent, 2004; Parent et al., 1998) and neutrophil-like HL-60 cell line (Servant et al., 
2000; Wang et al., 2002). These PI3Ps are critical in organizing the neutrophil’s leading 
edge, as shown by experiments in which pharmacologic inhibitors of PI3Ks block 
attractant-stimulated formation of actin polymers and pseudopods (Servant et al., 2000; 
Wang et al., 2002) by abrogating activation of small GTPases of the Rho family, 
including Rac and Cdc42 (Benard et al., 1999), which are known to promote formation of 
actin polymers (Ridley, 2001; Tapon and Hall, 1997). It has been shown recently by 
several groups (Srinivasan et al., 2003; Wang et al., 2002; Weiner et al., 2002) that PI3Ps 
and Rac serve as signals in a positive feedback loop that organizes the leading edge of 
HL-60 cells. While PI3Ps are required for activation of Rac, the reverse is also true: 
inhibiting Rac activation (with toxins or a dominant negative Rac mutant) prevents PI3P 
accumulation (Servant et al., 2000; Srinivasan et al., 2003; Wang et al., 2002). 
Furthermore, addition of exogenous PI(3,4,5)P3 can trigger the positive feedback loop 
directly, initiating accumulation of endogenous PI3Ps (Weiner et al., 2002), morphologic 
polarity, and motility in the absence of added chemoattractant (Verena, 2000; Weiner et 
al., 2002). These effects are completely blocked by PI3K inhibitors and toxins that inhibit 
activation of Rho GTPases, indicating that they depend on activation of both endogenous 
PI3P synthesis and Rac by the exogenous lipid. Finally, Rac stimulates PI3P 
accumulation, at least in part, via actin polymers that are generated in response to 
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activated Rac: either attractant or expression of constitutively active Rac can trigger 
persistent PI3P accumulation, but both effects are prevented when actin polymerization is 
blocked by latrunculin B, which sequesters actin monomers (Srinivasan et al., 2003; 
Wang et al., 2002). Finally, inactivation of Gi by pertussis toxin (PTX) abrogates 
frontness responses tested in neutrophils and differentiated HL-60 cells, including 
polymerization of actin, activation of Rac and Cdc42, and PI3P-dependent 
phosphorylation of Akt, although cell’s ability to form uropod was left intact (Wang et al., 
2002). In conclusion, the model for frontness in which activation of Gi triggers the 
feedback loop of PI3K, Rac, and F-actin explains the persistence of robust actin and 
PI3P-containing pseudopods during neutrophil chemotaxis. 
 
A backness signaling pathway suggests a model for neutrophil self-organizing polarity 
Previous studies suggest that in addition to the frontness signals, attractant 
receptors trigger a backness pathway that contributes to polarity: In contrast to the 
frontness pathway, which is triggered by Gi, the backness signaling pathway is initiated 
by G12 and G13 (Xu et al., 2003). Their downstream components include a Rho, a Rho-
dependent protein kinase (p160-ROCK), and activated myosin, which results in 
contraction of actomyosin complexes at the cell membranes at the trailing edge. At each 
step of the pathway the corresponding constitutively active mutants induced a global 
backness response: cells rounded up and failed to form actin polymers or recruit PH-
AKT-GFP (the PH domain of protein kinase Akt fused to GFP, used as a spatial probe for 
3′-phosphoinositol lipids) to the leading edge in response to fMLP, but instead 
accumulated activated myosin around the entire cell periphery. Conversely, inhibiting 
each of these steps with pharmacological drugs or dominant negative mutants impaired 
cell contractility at the back and caused cells to form an elongated tail. Myosin II-
mediated contractility is also involved in reducing the sensitivity of the back of the cells 
because abrogating the backness pathway renders the entire cell sensitive to fMLP 
stimulation and generates multiple pseudopods (Xu et al., 2003). 
This model explains, at least partially, how a neutrophil responding to fMLP 
adopts morphological polarity. From the receptor level, two divergent pathways 
involving distinct molecules are generated to induce actin polymerization and actin-
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myosin assemblies, respectively. Spatial segregation between these two actin assemblies 
in the membrane is possible due to mutual inhibition between these assemblies. Such 
mutual incompatibility and inhibition between frontness and backness may account for 
the ability of neutrophils and HL-60 cells to polarize in uniform concentrations of 
chemoattractant and to perform U-turns rather than simply reverse polarity in response to 
changes in the direction of the attractant gradient. The neutrophil follows its sensitive 
nose because positive feedback loops at the front and Rho/myosin-mediated contraction 
(inhibition) at the back render the pseudopod much more sensitive to PI3P- and Rac-
activating actions of the attractants (Xu et al., 2003).  
It is important to note that while the model has facilitated our understanding of 
how polarity occurs in neutrophil chemotaxis, it is not without limitations. It does not 
address the spatiotemporal dynamics of the activation of the two distinct pathways in 
neutrophils responding initially to chemoattractants in gradients; rather, it explains the 
polarity on the premise that both pathways are simultaneously active. Thus, the picture is 
unclear whether there is a temporal difference in the initial activation of two distinct 
pathways in response to the chemoattractants leading to the spatial segregation of two 
pathways within neutrophils. Future experiments addressing the precise spatiotemporal 
dynamics of the activities of the frontness and backness pathways will allow one to draw 
a more complete picture of polarity in neutrophil chemotaxis. For instance, in one 
speculative model following this idea, graded activation of one pathway (presumably the 
frontness pathway) corresponding to the extracellular chemoattractant gradient occurs 
prior to the activation of the other pathway, thereby preoccupying a portion within cells. 
The delayed activation of the other pathway (presumably the backness pathway) may 
follow, and because of the mutual inhibition between the two pathways, its signals may 
be limited to the cellular region where the first signal is relatively weak.  
  
Mechanical regulations in neutrophil chemotaxis are poorly understood 
While various biochemical regulatory mechanisms controlling neutrophil 
chemotaxis have been studied extensively, mechanical regulation that governs the 
persistent and rapid movement of neutrophils remains poorly understood. In particular, 
there is limited documentation of quantitative analysis of tractions in neutrophils. At the 
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time the thesis was conceived, only a single study (Smith et al., 2007) was available 
concerning measurement of traction during neutrophil chemotaxis. Though valuable, the 
study was limited in that the temporal resolution was inadequate (traction measurement 
interval of 1-2 minutes) to fully capture the traction dynamics occurring in fast migrating 
neutrophils and that the substrate stiffness used was much higher than what neutrophils 
normally encounter in physiological settings. Thus, the spatial and temporal dynamics, 
regulation and functions of tractions remain largely undefined and required a thorough 
examination.  
 
Traction in cell migration 
Why is traction important in motile cells? Cells crawling on two dimensional 
surfaces interact with their environment not only biochemically but also mechanically. In 
particular, the latter mode of interaction is thought to provide driving force for motile 
cells; in order to move forward, cells need to exert rearward traction forces (Dembo and 
Wang, 1999; Lauffenburger and Horwitz, 1996; Oliver, 1994).  
Current knowledge on traction in motile cells is mostly based on studies using 
slow moving cells such as fibroblasts. These cells show prominent adhesion structures 
with a relatively slow turnover rate, which can serve as robust anchorage sites between 
cell and extracellular matrix (ECM) and transmit the traction forces. In addition, 
relatively low time resolution required to capture the traction dynamics rendered these 
slow migrating cells a preferable choice to study than their fast moving counterparts.  
In slow migrating cells such as fibroblasts, tractions are broadly organized into 
two distinct zones. In the lamellipodial region, large centripetal tractions are found along 
the periphery of the cells, which get countered by tractions developing at the 
lamellipodia-lamella border (Munevar, 2001). In marked contrast, the trailing edge 
contains only a few isolated spots of weak tractions which are in parallel with the overall 
direction of cell motility. Such front-to-back asymmetry in traction pattern agrees well 
with the frontal towing model (Beningo and Wang, 2002; Dembo and Wang, 1999; 
DiMilla et al., 1991; Munevar, 2001). The model is based on the idea of differential 
adhesion strengths in motile cells, i.e., front adhesions are strong whereas the back 
adhesions are weak. In this model, contraction of actin cytoskeleton causes tension to be 
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transmitted to those two classes of adhesion, pulling the front adhesions rearward and 
pushing the back adhesions forward. Relatively strong adhesions at the leading edge 
withstand such backward pulling force and provide counter force to cells to move 
forward. In contrast, the relatively weak adhesions at the trailing edge are dissociated 
upon force transmission, causing the cytosolic flow and protrusion of front membrane. 
While tractions provide slow migrating cells with driving force at the cellular 
level, it functions to facilitate the strengthening of nascent leading-edge adhesions at the 
molecular level (Balaban et al., 2001). Slow moving cells such as fibroblasts assemble 
transient adhesions called focal complexes at the leading edge, which mature into more 
stable focal adhesions (Rottner et al., 1999). Development of focal adhesions is essential 
for persistent protrusion of lamellipodia, as focal adhesions provide robust anchors to the 
extracellular matrix (ECM), allowing actomyosin contractile forces to pull the cell body 
forward without detachment from ECM. In agreement with this, persistent traction spots 
at the leading edge correlate well with both the development of further protrusion and the 
direction of overall cell migration (Munevar, 2001).  
In fast migrating cells such as Dictyostelium discoideum, the asymmetrical 
distribution of tractions – yet, a reversed one compared to that of fibroblasts - has been 
reported, with higher traction in the rear and lower traction at the front (Lombardi et al., 
2007). Such asymmetry in traction has led some to hypothesize a model in which the rear 
contraction or squeezing induces the dissociation of back adhesions as well as driving a 
forward cytoplasmic flow and protrusion of the lamellipodia (Condeelis, 1993; Yanai, 
2004; Yanai, 1996). However, the pattern, regulation and functions of traction in 
neutrophil chemotaxis need more thorough examination as mentioned above.     
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CHAPTER 2 
 
SPATIOTEMPORAL ORGANIZATION OF TRACTIONS  
DURING NEUTROPHIL CHEMOTAXIS 
 
Introduction 
As discussed in the Chapter 1, traction in neutrophil chemotaxis has not been 
examined in a rigorous fashion, thus requiring a careful analysis. In this chapter, I address 
the spatiotemporal pattern of traction during neutrophil chemotaxis. Highly dynamic 
tractions are found in both leading and trailing edges of neutrophils during chemotaxis. 
Tractions at both edges oscillate periodically with a time offset.     
 
Materials and methods1 
Isolation of primary neutrophils and HL-60 cell culture 
Primary neutrophils were isolated from venous blood from healthy human donors. 
Blood was collected into heparin-containing Vacutainer tubes (BD Biosciences) and 
neutrophil isolation procedure was performed within 30 min of blood collection using 
PMN isolation medium (Matrix). Red blood cell contaminants were removed by Red 
Blood Cell Lysis buffer (Roche), producing more than 97% of neutrophil purity. 
Neutrophils were suspended in RPMI 1640 medium supplemented with 10% fetal bovine 
serum at 37°C until the time of experiments conducted within 8 h after isolation. 
Cultivation and differentiation of HL-60 cells were as described (Wang et al., 
2002). 
 
Polyacrylamide gel substrates, traction force microscopy (TFM) and data analysis 
Polyacrylamide gels were prepared as described (Pelham and Wang, 1999). Red 
fluorescent microspheres (0.2 µm, Molecular Pobes) were embedded in gels for traction 
detection, and the gels were coated with 10 µg/ml human fibronectin. The elastic Young 
modulus of the polyacrylamide gels was 3.5 kPa (5% acrylamide; 0.10% bis-acrylamide) 
                                                 
1 In the case of a method concerning multiple chapters, the explanation was given only once in the first 
chapter the given method appears. 
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(Engler et al., 2004; Tolic-Norrelykke et al., 2002) . 100 kPa gels, were generated as 
described by Oakes et al (Oakes et al., 2009).  Briefly, dHL-60 cells or primary 
neutrophils (1.0 x 105) with or without various treatments were allowed to adhere to the 
fibronectin-coated polyacrylamide gel for 10 min at 37°C and migrate toward the 
micropipette containing 10 µM fMLP for 5 min. Traction force microscopy was 
performed using Andor Technology Revolution System Spinning Disk Confocal 
Microscopy system (Andor) coupled to an Olympus IX71 inverted microscope with 
Olympus 100x APO/1.4 NA objective. The working distance of the objective is ~0.13 
mm, which far exceeds the thickness of the polyacrylamide gel (75 m and the cell (~5 
m) combined. HL-60 cells stably expressing GFP were used for TFM to track the 
outline of cells during the migration. Primary neutrophils were labeled with calcein AM 
(30 min, Invitrogen) or DiO (5 min, Invitrogen) and washed once with RPMI 1640 media 
prior to imaging studies. 532 (20 mW) and 635 (25 mW) nm diode-pumped solid state 
(DPSS) laser lines were used to excite the fluorophores within the cell and the beads. The 
exposure time for both channels was 21 msec. Using iXon EM+ DU-897 back 
illuminated EMCCD (Andor Technology), images of cells expressing GFP and 
fluorescent beads were captured interchangeably every 0.8 sec for each fluorescent 
channel during stimulation and after the cells completely detached from the substrate. 
Images of the beads were analyzed by a custom-made program to calculate bead 
displacement and to generate traction maps. Images of beads after cell detachment, 
therefore traction-free, were used as a reference. 
For traction analysis, the leading edge of a polarized neutrophil was defined as the 
area within the first 3 m of the cell (for control cells and cells treated with Y-27632), 
while the rest of the cell was defined as the trailing edge. For ML-7-treated, MLCK-
depleted or blebbistatin-treated cells, the leading edge was defined as the area within the 
first 2.2 m of the cell. These definitions were based upon quantifications of the leading-
edge areas in HL-60 cells expressing the frontness markers such as YFP-actin and 
primary neutrophils stained with rhodamine-phalloidin for F-actin with or without the 
drug treatments or MLCK depletion. The average tractions at the leading and trailing 
edges were calculated from the traction maps generated by the use of TFM. 
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To determine the periodicity of the front and rear tractions, Fourier analysis was 
performed using the traction values obtained from the TFM. The analysis was done using 
the built-in MATLAB “fft” (Fast Fourier Transform) function to transform the original 
time-domain traction signals into frequency domain. The PSD plots were then generated 
based on the results from the Fourier transform analysis. 
To analyze cross correlation between tractions at the leading and trailing edges 
and to calculate the cross-correlation coefficient (r) (Manders et al., 1992), a customized 
MATLAB (Mathworks) program was developed:  
r
  
   




i
i
i
i
i
ii
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BBFF
22
, 
where Fi and Bi are the mean traction values of the front and back at time point i, and F  
and B  are the averaged mean traction values of the front and back over entire time. To 
examine the time lag between tractions at the leading and trailing edges, the values for 
tractions at the front were shifted in time with those at the back fixed.   
 
Results 
Tractions at both edges of chemotaxing neutrophils oscillate periodically with a time 
offset 
To assess the spatial and temporal pattern of tractions in neutrophils during 
chemotaxis, we plated neutrophils on a flexible substrate coated with fibronectin and 
stimulated them with a point source of the chemoattractant formyl-Met-Leu-Phe (fMLP). 
Fibronectin has been widely used as a substrate for the study of neutrophil chemotaxis 
(Bain et al., 2003; Oakes et al., 2009; Wang et al., 2002). We used a substrate stiffness of 
3.5 kPa, resembling the stiffness of tissue cells such as endothelial cells (1-5 kPa) 
(Janmey and McCulloch, 2007). We used both the neutrophil-like differentiated HL-60 
(dHL-60) cells and human primary neutrophils. HL-60 cells, when differentiated, exhibit 
neutrophil-like morphologies, polarize and migrate in gradients (or in uniform 
concentrations) of attractants at rates comparable to those of neutrophils from peripheral 
blood, but unlike primary neutrophils they can be continuously cultured and are 
genetically tractable (Servant et al., 2000; Wang et al., 2002; Xu et al., 2003).  Therefore, 
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HL-60 cells have been used widely as a model for studying neutrophil polarity and 
chemotaxis (Bodin and Welch, 2005; Gomez-Mouton et al., 2004; Hauert et al., 2002; 
Schymeinsky et al., 2006). We detected tractions at both the leading and the trailing edge 
of dHL-60 cells (Figure 2.1A). Tractions were not distributed evenly at the leading or the 
trailing edge but instead were often concentrated in small regions that ranged from 1 to 4 
m in diameter (Figure 2.1A; Supplementary Movie S1). Those “hot spots” of tractions 
varied in their lifetime, with some persisting for several seconds and others quite transient 
with a subsecond lifetime (data not shown). Most traction, especially around the cell 
periphery, was directed toward the cell center (data not shown).   
Time-course analysis of tractions in cells moving towards fMLP revealed a highly 
dynamic temporal pattern: the mean level of tractions at both edges oscillated during 
migration (100-400 Pa) (Figure 2.1A-2.1B) (The average tractions are summarized in 
Table 2.1). Fast-Fourier transform (FFT) analysis of the time-domain signals revealed 
periodicity of tractions in chemotaxing neutrophils: the Power Spectral Density (PSD) 
plots of results from FFT analysis demonstrated a single pronounced peak at 4.8 ±1.4 sec 
for tractions at the leading edge and 4.8 ±1.6 sec for those at the trailing edge 
(means±SEM, n=9 cells) (Figure 2.1C).  Primary human neutrophils showed a similar 
pattern of tractions. Tractions were detected at both edges, where they oscillated at a 
periodicity of 4.7±1.5 sec and 4.7 ± 1.0 sec, respectively (means±SEM, n=6 cells) (Fig. 
2.1D). Interestingly, oscillations of tractions at the two edges were out of phase (Figure 
2.1A), and the tractions at the front preceded those at the back by 0.80±0.23 sec 
[means±SEM (n=9 cells); p<0.0001] for dHL-60 cells and 0.40±0.16 sec [means±SEM 
(n=6 cells); p<0.001] for primary cells, as shown by a cross-correlation analysis, which 
computed the time offsets between tractions at the front and the back by shifting the two 
data sets relative to each other (Figure 2.1E and 2.1F). The conserved periodic and out-
of-phase behavior of tractions at the neutrophil’s front and back suggests a biomechanical 
mechanism that drives coordinated movements of neutrophils via differential contractile 
stresses exerted onto the substrate. 
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Figures and Tables 
 
 
 
Figure 2.1  
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Figure 2.1 (cont.) Spatiotemporal dynamics of tractions during neutrophil 
chemotaxis 
(A) dHL-60 cells were allowed to migrate toward chemoattractant-containing 
micropipette (fMLP, 10 μM) on a FN-coated elastic polyacrylamide gel for the times 
indicated. The speed for cell migration is approximately 2.0 μm/minute, lower than the 
speed of cells on FN-coated glass (2.4 μm/minute). The cells also exhibit normal tail 
retraction on the elastic gel (data not shown). Traction maps of the cell are shown. 
Pseudocolor bar representing tractions is given in Pascal (Pa). Scale bar represents 5 μm. 
Arrow indicates the direction of fMLP gradient. The leading edge of a polarized 
neutrophil was defined as the area within the first 3 μm of the cell (marked by a white 
line), whereas the rest of the cell was defined as the trailing edge (“Polyacrylamide gel 
substrates, TFM, and data analysis”). The image series shows part (~7.2 seconds, for 
which the cell traveled ~0.24 μm) of the whole migratory response. The video of the cell 
in panel A is available in supplemental data. (B) Time series of traction maps from panel 
A (with 3 additional time points) was analyzed by a customized MATLAB program to 
determine the average tractions in both leading edge (front) and trailing edge (back) of 
the cells in a time-dependent manner. The graph shows part (~9 seconds) of the whole 
migratory response. The x-axis indicates time in seconds; y-axis is in Pascal (Pa). The 
mean levels of tractions at the leading and the trailing edges were comparable. (C) PSD 
plots of tractions at the leading (left panel) and the trailing edge (right panel) of a 
migratory dHL-60 cell. PSD plots were generated based on the results from Fourier 
analysis of the traction values. The y-axis represents the power spectral density 
normalized to the highest peak value (~1); x-axis shows the oscillation frequency (Hertz; 
top) or period (seconds; bottom). Nine cells were analyzed, and a representative cell is 
shown. (D) PSD plots of tractions at the leading edge (left panel) and the trailing edge 
(right panel) of a migratory primary neutrophil. Six cells were analyzed, and data from a 
representative cell are shown. (E) Left panel: Cross-correlation between tractions at the 
leading edge and the trailing edge against time offset during migration for individual 
dHL-60 cells. Dotted lines indicate zero offset. Note that the back traction lags the front 
traction as indicated by the maximum cross-correlation at time offset of 0.8 seconds. Data 
from 3 representative cells are shown. Time bar represents 24 seconds. Right panel: 
Summary of time offsets between leading edges and trailing edges (n ~9 cells) in dHL-60 
cells. (F) Left panel: Cross-correlation between tractions at the leading and the trailing 
edges against time offset during migration for individual primary neutrophils. Data from 
2 representative cells are shown. Right panel: Summary of time offsets between leading 
edges and trailing edges (n=6 cells) in primary neutrophils. 
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Table 2.1 Magnitude of tractions in migrating neutrophils 
dHL-60 cells or primary neutrophils were allowed to migrate toward a chemoattractant-
containing micropipette (fMLP, 10 μM) on a FN-coated elastic polyacrylamide gel for ~ 
5 min. Prior to the chemotaxis assay, cells were treated with various pharmacological 
inhibitors (ML-7, Blebbistatin or Y-27632) or siRNA for MLCK. Polyacrylamide gels 
with two different stiffness, 3.5 and 100 kPa, were used in the assay. Average traction 
values at the leading and the trailing edges of the neutrophils undergoing chemotaxis 
under various conditions were measured and are summarized in the table.  
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CHAPTER 3 
 
NONMUSCLE MYOSIN II REGULATES TRACTION AND 
MOTILITY IN NEUTROPHIL CHEMOTAXIS 
 
Introduction 
In this chapter, I address the role of nonmuscle myosin II in regulating traction 
and cell motility during neutrophil chemotaxis. Nonmuscle myosin II can induce 
contraction of the filamentous actin fibers. When such actin fibers are linked to the ECM 
through adhesion molecules, the pulling action of nonmuscle myosin II on actin can 
generate traction. Therefore we asked whether myosin II regulates traction in neutrophil 
chemotaxis. We found that nonmuscle myosin II is localized to both leading and trailing 
edges in polarized neutrophils. Myosin II is required for magnitude and periodicity of 
traction in neutrophils. In addition, myosin II activities are essential for smooth, 
persistent motility of neutrophils by promoting the stability of the leading edge and the 
contraction of the trailing edge. In particular, by comparing the differential effects of 
inhibiting Myosin II or ROCK – a myosin II kinase which is distinctly localized at the 
trailing edge and involved in contraction of the cell rear - on cell motility, we deduced 
that myosin II activities at the leading edge specifically function to promote stable 
protrusion of the leading edge.        
 
Materials and methods 
Reagents 
Human fibrinogen and human serum albumin (low endotoxin) were from Sigma-
Aldrich. Y-27632 was from Calbiochem. fMLP was from BioChemika. Human 
fibronectin was from BD Biosciences. Alexa fluor 488 phalloidin and rhodamine-
phalloidin were from Molecular Probes. Rabbit anti-nonmuscle myosin II heavy chain A 
and B antibody were from Covance (Emeryville, CA).  
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DNA constructs  
EGFP-tagged sMLCK construct was a gift from Anne Bresnick (Albert Einstein 
College of Medicine) (Poperechnaya et al., 2000). EGFP-tagged α5 integrin (Laukaitis et 
al., 2001) and mCherry-tagged myosin IIA (Vicente-Manzanares et al., 2007) were 
kindly provided by Rick Horwitz (University of Virginia). GFP-actin was from Clonetech. 
Information on PAK-PBD-YFP and PH-AKT-YFP was reported (Wang et al., 2002; Xu 
et al., 2003). GST-FN III9-11 was also described (Orr et al., 2006). 
 
Western blotting 
For western analysis, 1-2 million cells in modified HBSS buffer without serum 
were stimulated with or without 100 nM fMLP at RT. Stimulation was stopped by adding 
2X Laemmli sample buffer with a cocktail of proteases and β-mercaptoethanol. Equal 
amounts of protein lysates were loaded on reducing SDS-PAGE gels. After 
electrophoresis, gels were immunoblotted with primary antibodies against proteins of 
interest, followed by appropriate secondary antibodies. Primary antibodies used included 
anti-antibody mouse anti-MLCK (1:1000), anti-nonmuscle myosin II heavy chain A 
(1:500), anti-nonmuscle myosin II heavy chain B (1:500), rabbit anti-Akt antibody 
(1:1000) and anti-phospho [Ser473]-Akt (1:200). 
 
Immunostaining and confocal fluorescence microscopy and 3D reconstruction 
For immunofluorescence in fixed cells, cells were stimulated with 1 µM fMLP in 
modified HBSS buffer (mHBSS) for the indicated time. Cells were extracted with 0.2% 
Triton X-100 for 10 min at room temperature (RT), fixed in 3.7% paraformaldehyde and 
immunostained. Antibodies were used at a dilutions of 1:200 (p-MRLC) and 1:500 
(myosin heavy chain IIA) and immunostaining was performed as described (Wang et al., 
2002). F-actin was assessed by incubating for 10 min at RT with 0.2 unit of Alexa Fluor 
488 conjugated phalloidin. Immunostained cells were imaged using epifluorescence 
microscopy or confocal fluorescence microscopy. 
Confocal optical sectioning was performed with an Andor Technology Revolution 
System Spinning Disk Confocal Microscopy system (Andor) coupled to an Olympus 
IX71 inverted microscope with Olympus 100x APO/1.4 NA objective. The refraction 
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index of immersion media was 1.515. Theoretical xy- and z-axes resolutions were 0.159 
and 0.2 μm, respectively. Images were obtained using iXon EM+ DU-897 back 
illuminated EMCCD (Andor Technology). Confocal images were taken with 0.2 μm step 
size. Upon acquisition, the confocal images were deconvoluted with Autoquant X 2.1 
software (Media Cybernetics, Inc., Silver Spring MD). The 3D structure of the 
actomyosin network was reconstructed from the deconvoluted images using IMARIS 
software (Bitplane).  
 
Cell transfection and live cell imaging  
For transient transfections, the AMAXA nucleofection system was used. 
Differentiated HL-60 cells (2 x 107, on day 5–6 after DMSO addition) were spun down 
and resuspended in nucleofector solution V. DNA (5 µg) or siRNA (3 µg) was added to 
the cells, and the cell-DNA mixture was subjected to nucleofection (program T-19). 
Nucleofected cells were transferred to 20 ml of complete medium. Subsequent assays 
were performed 3-6 h for the expression vectors and 24–48 h for siRNAs after 
transfection.  
For live-cell imaging, cells were plated on human fibronectin-coated surface and 
stimulated either with a uniform concentration of 1 µM fMLP or a point source of 10 µM 
fMLP from a micropipette (internal diameter of 1 µm, pulled from a glass capillary), as 
described (Servant et al., 2000). Differential interference contrast (DIC) images, 
fluorescent images, and combined DIC/fluorescence images were collected with a Zeiss 
40X NA 1.30 Fluar DIC objective or 63X NA 1.4 Plan Apochromat DIC objective on a 
Zeiss Axiovert 200M microscope. All images were collected with a cooled charge-
coupled device camera (AxioCam MR3, Zeiss) and processed by ImageJ programs. 
 
Lentivirus-mediated myosin IIA knockdown 
The pKLO.1-puro lentiviral vectors containing scramble or myosin IIA-targeting 
shRNAs were purchased from Sigma. We used the Viralpower Lentivirus Packaging 
System (Invitrogen) to generate lentivirus according to the manufacturer’s instructions. 
Briefly, HEK293T cells were plated and transfected on the second day with shRNA-
containing plasmids using the Fugene 6 reagent (Roche). The medium was replaced the 
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next day with the virus packaging medium containing DMEM, 30% FBS, 1 mM sodium 
pyruvate, 4mM glutamine. Supernatant containing the lentivirus was collected 48-72 h 
later and was concentrated with ultracentrifugation (20,000 rpm, 1 h).  
 Concentrated viruses were added to differentiating HL-60 cells (on day 2) and 
incubated for 12 h. A multiplicity of infection (MOI) of 100 was used. Polybrene (6 
μg/mL) (Sigma) was also added to the medium to improve the infection efficiency. 
Virus-containing medium was replaced with fresh culture medium, and cells were 
continuously cultivated for 4-5 d before subsequent analysis.  
 
Results 
Myosin II is localized at both edges of polarized neutrophils 
Myosin II filaments can apply forces to move actin filaments relative to each 
other. During fibroblast migration, the contractile force generated by the actin-myosin 
cytoskeleton causes tractions on the underlying substrate by propagating through the 
actin-integrin-ECM link (Geiger and Bershadsky, 2002). We therefore assessed myosin II 
expression and spatial localization in neutrophils. Experiments with isoform-specific 
antibodies demonstrated that neutrophils mainly expressed myosin IIA (Figure 3.1A), 
consistent with an earlier report (Maupin et al., 1994). We then assessed the spatial 
localization of myosin II using antibodies against total myosin IIA, myosin regulatory 
light chain (MRLC) phosphorylated at Ser19 [p[19]-MRLC (Xu et al., 2003), the 
activated form of MRLC] and an mCherry-tagged myosin IIA (mCherry-myosin IIA) 
(Vicente-Manzanares et al., 2007) in fixed or live dHL-60 cells. Both total and activated 
myosin II and the mCherry-tagged fusion protein were located mostly at the trailing edge 
of polarized neutrophils (69%, 68% and 72% of total fluorescence intensity for myosin 
IIA, p[19]-MRLC and mCherry-myosin IIA, respectively) (Figure 3.1B and 3.1C; 
Supplementary Movies S2 and S3), consistent with earlier reports (Weiner et al., 2006; 
Xu et al., 2003). There was a considerable amount of myosin IIA localization at the front 
(31%, 32%, and 28%, respectively; Figure 3.1B and 3.1C), as described previously in 
studies on primary neutrophils (Bain et al., 2003; Pestonjamasp et al., 2006). Using 
confocal fluorescence microscopy combined with 3D reconstruction, we found that 
myosin IIA was enriched around the periphery of the uropod (trailing edge) and 
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distributed vertically and somewhat diffusely in the pseudopodia (Figure 3.1D; 
Supplementary Movies S4 and S5). Interestingly, although F-actin was highly enriched at 
the leading edge, it was also detected throughout the periphery of the cell including at the 
back of the cell (Figure 3.1D; Supplementary Movies S4 and S5). 
 
Myosin II controls tractions and is required for neutrophil chemotaxis 
We next impaired the function of myosin II in neutrophils and assessed the effect 
on tractions. As expected, inhibiting myosin II with blebbistatin (a specific myosin II 
inhibitor) in dHL-60 cells and primary neutrophils substantially reduced the tractions at 
both the leading and the trailing edge by up to 50% (Figure 3.2A and 3.2B) (Table 2.1). 
Remarkably, myosin II inhibition abolished the periodicity of tractions at both edges: 
myosin II-inhibited cells no longer exhibited periodic oscillations of tractions but instead 
showed random fluctuations, as shown by the lack of distinct frequencies/periods in all 
cells analyzed (n=10 for dHL-60 cells; n=6 for primary neutrophils) (Figure 3.2C and 
Figure 3.3A-B). Thus, myosin II is necessary for development and periodicity of tractions 
in neutrophils and serves as the molecular basis for tractions in neutrophils during 
chemotaxis. 
Inhibition or depletion of myosin II also impaired neutrophil directional migration. 
In the presence of an fMLP gradient delivered by the micropipette, both dHL-60 cells and 
primary neutrophils, when plated on fibronectin-coated cover glass, polarized and rapidly 
migrated in the direction of the pipette with well-developed pseudopodia (Figure 3.4A 
and Figure 4.3A; Supplementary Movie S6). In contrast, cells treated with blebbistatin 
failed to persist in forward movement and formed poorly-developed, unstable, leading 
edges (Figure 3.4A; Supplementary Movie S7; data not shown). Differential interference 
contrast (DIC) kymographs of cells responding to the pipette stimulation demonstrated 
that blebbistatin-treated cells often retracted their leading edges after initial protrusion 
while untreated cells exhibited a persistent and progressive pattern of leading-edge 
protrusion (Figure 3.4B and Figure 3.5A-H). In addition, blebbistatin treatment caused 
defects in contractility at the back of the cells, which in many cases exhibited long, 
stretched tails (Figure 3.4A, Figure 3.5D and 3.5H), as previously reported (Xu et al., 
2003). Differentiated HL-60 cells in which myosin IIA was depleted by small hairpin (sh) 
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RNAs exhibited similar (albeit less profound) defects (Figure 3.4A-B, Figure 3.5A-D and 
Figure 3.5I; Supplementary Movie S8). Thus, myosin II inhibition (or depletion) caused 
neutrophils to form unstable leading edges and long tails. In contrast, inhibition of p160-
ROCK, a key component of the previously documented “backness” pathway that 
regulates neutrophil polarity and chemotaxis (Wong et al., 2006; Xu et al., 2003), reduced 
the level of activated myosin II at the back (Figure 4.7A), induced neutrophils to form 
long stretched tails (Figure 3.4A) (Alblas et al., 2001), but failed to affect protrusion of 
the leading edge (Figure 3.4A-B, and Figure 3.5A-H; Supplementary Movie S9). The 
backness pathway promotes localized activation of Rho and its downstream kinase p160-
ROCK, leading to spatial activation of myosin II at the trailing edge (Wong et al., 2006; 
Xu et al., 2003). Based on the differential effects of myosin II and p160-ROCK inhibition 
on protrusion, we inferred that myosin II activity at the neutrophil’s leading edge is 
necessary for stabilizing the protrusion response.  
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Figures 
 
 
 
 
 
 
 
 
 
Figure 3.1 Expression and subcellular localization of nonmuscle myosin II in 
neutrophil chemotaxis  
(A) Western blot analysis of primary human neutrophils and dHL-60 cells probed with 
mAbs specific for myosin II heavy chain isoform A (MHCIIA) and B (MHCIIB). 
Embryonic stem cells (human; denoted as hESC) expressed both myosin IIA and IIB and 
were used as a positive control. α-tubulin was used as a loading control. (B) dHL-60 cells 
were stimulated for 3 min by a uniform concentration of 1 µM fMLP. Cells were fixed 
with 3.7 % paraformaldehyde and stained with a specific anti-myosin heavy chain IIA 
(MHCIIA) antibody, anti-p[Ser19]MRLC antibody, and rhodamine-conjugated phalloidin 
to localize filamentous actin (F-actin). The corresponding DIC image is also shown. Bar, 
10 μm. (C) dHL-60 cells were transfected with mCherry-myosin IIA (mChe-myoIIA) and 
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Figure 3.1 (cont.) stimulated by a micropipette containing 10 μM fMLP for the indicated 
times. mCherry-myosin IIA fluorescence and the corresponding DIC images are shown. 
Arrows point to the locations of myosin IIA at the leading and trailing edge. Bar, 10 μm. 
The movie of the cell in (C) is available in the Appendix. (D) Schematic view of myosin 
IIA localization in a polarized neutrophil after fMLP stimulation. The representation 
shows a cross-section of the neutrophil and is based on confocal fluorescence microscopy 
combined with 3D reconstruction. The movies showing 3D views of myosin IIA 
immunofluorescence are available (Supplementary Movies S4 and S5). 
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Figure 3.2 Myosin II controls tractions and is necessary for neutrophil chemotaxis 
 (A) dHL-60 cells pretreated with blebbistatin (100 μM, 30 min) were allowed to migrate 
toward chemoattractant-containing micropipette (fMLP, 10 µM) on a fibronectin-coated 
elastic polyacrylamide gel for the indicated times. Cells treated with blebbistatin migrated 
at 1.0 μm/min on the elastic gel. Traction maps of the cell are shown. Pseudocolor bar 
representing traction force is given in Pascal (Pa). Scale bar = 10 µm. The leading edge 
(within the first 2.2 μm of the cell) is marked by a white line (see Materials and Methods). 
The image series shows part (5.6 sec) of the whole migratory response. (B) Time series 
of traction maps from (A) (with four additional time points) was analyzed by a 
customized MATLAB program to determine the average tractions in both leading (front) 
and trailing edges (back) of the cells in a time-dependent manner. The graph shows part 
(~9.6 sec) of the whole migratory response. x axis indicates time in sec. y axis is in 
Pascal (Pa). (C) PSD plots of tractions at the leading (left panel) and the trailing edge 
(right panel) of a migratory cell pretreated with blebbistatin (100 μM, 30 min). The whole 
migratory response was analyzed. y axis represents the power spectral density normalized 
to the highest peak value (=1). x axis shows the oscillation frequency (Hz) (top) or period 
(s) (bottom). Cells depleted of myosin II exhibited similar response (not shown). 10 cells 
were analyzed, and a representative cell is shown. Additional plots are shown in Figure 
3.3.   
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Figure 3.3 Myosin inhibition abolishes the periodicity of traction in neutrophils 
(A) PSD plots of tractions at the leading (left panel) and the trailing edge (right panel) of 
three dHL-60 cells treated with blebbistatin (100 M, 30 min). Tractions values from 
three cells were analyzed and combined in one plot. See Figure 2.1 legends for more 
details. (B) PSD plots of tractions at the leading (left panel) and the trailing edge (right 
panel) of a primary neutrophil treated with blebbistatin (100 M, 30 min). 5 cells were 
analyzed, and a representative cell is shown. 
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Figure 3.4 Myosin II activity at the leading edge is required for stable protrusion in 
neutrophil chemotaxis  
(A) Before exposure to attractant supplied by a micropipette containing 10 μM fMLP, 
dHL-60 cells were not pretreated (control), were pretreated with blebbistatin (Blebbis, 
100 μM, 30 min), were infected with lentivirus containing myosin IIA-targeting shRNAs 
(MyoII KD), or were pretreated with Y-27632 (30 μM, 30 min). The three images in each 
row show the positions of individual cells (each identified with a superimposed letter) 
after the indicated times of exposure to fMLP. White and black arrows point to the 
poorly-developed leading edges and long stretched tails, respectively. Cells infected with 
virus containing a scramble shRNA exhibited similar response to uninfected control cells. 
Lower doses of blebbistatin (≤50 μM) were tested, which required prolonged period of 
incubation to exert the same effects as 100 μM blebbistatin (data not shown). Scale bar, 
10 μm. Movies of cells with or without treatments are available in the Appendix. (B) DIC 
kymographs of a dHL-60 cell untreated or treated with inhibitors or myosin IIA shRNAs 
migrating toward an fMLP (10 µM)-containing micropipette. The left panel shows a 
portion of the neutrophil’s leading edge under various conditions. The dotted rectangles 
indicate the regions of the cell used to generate the kymographs (prior to fMLP 
stimulation). The actual lengths of the rectangles are 20 µm in the direction of the arrow. 
White scale bar =1 µm. The right panel shows the DIC kymographs. White scale bar=5 
µm. In both panels white arrows indicate the direction of protrusion. Cells a, d, f and h in 
(B) were used for the analysis. ~8 min of migration was recorded. 
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Figure 3.5  
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Figure 3.5 (cont.) Myosin II activity at the leading edge is required for stable 
protrusion in neutrophil chemotaxis  
(A and B) Speed of protrusion (A) and retraction frequency (B) of the leading edge in 
cells responding to a gradient of fMLP delivered by a micropipette. dHL-60 cells were 
not pretreated (control), pretreated with blebbistatin (Blebbis, 100 μM, 30 min), infected 
with lentivirus containing myosin IIA-targeting shRNAs (MyoII KD), or pretreated with 
Y-27632 (30 μM, 30 min). The value are means ± SEM (n = 27 for control, 26 for cells 
treated with Blebbistatin, 24 for myosin IIA-depleted cells, and 28 for cells treated cell 
Y-27632. Student t tests compared data between experimental groups.  Results 
significantly different from those of control are indicated by asterisks (*, p < 0.0001; **; 
p < 0.001). (C and D) Percentage of dHL-60 cells demonstrating leading-edge retractions 
(C) and long stretched tails (D) when exposed to fMLP gradients. Cells retracting their 
leading edges at least once during migration were scored as positive. To define cells with 
long tails, we calculated ratios between the length and width in individual cells and used 
2 as a cut-off value. Each bar represents the mean+SEM (error bars) of different numbers 
of cells that were tested in multiple experiments: 30 control cells and 27, 24, and 30 cells 
for Blebbistatin, myosin IIA depletion, and Y-27632, respectively. Asterisks indicate that 
the value for cells with the treatments differs from the corresponding control by P < 
0.0001. (E-H) The same set of analysis for primary human neutrophils, which were not 
pretreated (control), pretreated with blebbistatin (Blebbis, 100 μM, 30 min), or pretreated 
with Y-27632 (30 μM, 30 min). The value are means ± SEM (n = 19 for control, 21 for 
cells treated with Blebbistatin, and 18 for cells treated cell Y-27632. Student t tests 
compared data between experimental groups.  Results significantly different from those 
of control are indicated by asterisks (*, p < 0.0001). (I) Western blot of myosin IIA in 
dHL-60 cells with or without myosin IIA depletion. Infection of cells with viruses 
containing three separate myosin IIA-targeting sequences effectively depleted myosin 
IIA, when compared with cells without infection (no infect.) or cells infected with viruses 
containing a scramble shRNA or three myosin IIA-specific shRNAs. The shRNA 
sequence 29464 was used in Figure 3.4A. α-tubulin was a loading control. A typical 
experiment from four separate experiments is shown. 
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CHAPTER 4 
 
MLCK-MEDIATED ACTOMYOSIN CONTRACTILITY IS 
REQUIRED FOR TRACTION AND PROMOTES LEADING EDGE 
STABILITY BY REGULATING α5β1-INTEGRIN ACTIVATION 
 
Introduction 
In this chapter, I address the role of myosin light chain kinase (MLCK) in 
controlling myosin II activities, traction and integrin activities in neutrophil chemotaxis. 
MLCK is known to be involved in myosin II activation in other motile cells. Therefore, 
we asked whether MLCK regulates myosin II in neutrophils. We found that MLCK is 
recruited selectively to the leading edge upon chemoattractant-mediated activation of 
neutrophils and activates myosin II at the leading edge. Such MLCK-mediated 
actomyosin contractility is important for generating periodic traction pattern in 
neutrophils. Furthermore, MLCK-driven contractile force allows stable protrusion of the 
leading edge by regulating α5β1-integrin activation.      
 
Materials and methods  
Reagents 
ML-7 was from Sigma-Aldrich. Human recombinant ICAM-1 was from R&D 
Systems. ON-TARGETplus SMARTpool siRNAs containing four siRNAs specifically 
targeting human MLCK, non-specific siRNAs and siGLO were from Dharmacon. The 
GRADSP and GRGDSP peptides were from Biomol. Mouse or rabbit anti-MLCK 
antibodies were from Sigma-Aldrich or generated as described (Wilson et al., 1991). 
Mouse anti-GST antibody was from Santa Cruz Biotechnology. Rabbit anti-phospho 
[Ser19] myosin light chain antibody, rabbit anti-Akt antibody, and rabbit anti-phospho 
[Ser473]-Akt antibody were from Cell Signaling Technology.  
 
Adhesion assay 
Neutrophil adhesion to 96-well tissue culture plate was evaluated as described by 
Ryu et al. (Ryu et al., 2000). After stimulation by chemoattractant, cells pretreated with 
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or without ML-7 were allowed to adhere to a 96 well-plate, which was coated with 
fibronectin (100 µg/ml) and blocked with 2% BSA in PBS, at 37°C for 30 min. Non-
adherent cells were removed by washing, and adherent cells were fixed with 3.7% PFA 
and stained with crystal violet (0.1% in 10% methanol). Stained cells were thoroughly 
washed and lysed with 1% SDS, and the absorbance from each sample was measured at 
590 nm by a microplate reader (SpectraMax M2).  
 
Micropipette assay in suspension 
The procedure was modified from a previous report (Zhelev et al., 2004). 
Micropipettes for holding a cell and applying chemoattractant were mounted on the 
microscope stage. Eppendorf's programmable micromanipulator, the TransferMan NK 2, 
was used in the holding (left) side, while Injectman NI 2 was used for application of 
chemoattractant (right side). A single, round non-stimulated neutrophil was held in a 
holding pipette with an internal diameter of 5 µm (World Precision Instruments). Another 
pipette with an internal diameter of 1 µm was filled with 10 µM fMLP and positioned 5 
µm from the cell surface. Suspended cells were gently held with CellTram Air connected 
to TransferMan NK 2 while precise delivery of chemoattractants was carried out from the 
right side with CellTram Vario. Chemoattractant-containing solution was blown over the 
cell, which initiated the extension of a single pseudopod. Pseudopod extension was 
observed in an inverted microscope (Leica DM IRE2) with a 40X objective. Images were 
captured with a charge-coupled device camera (Hamamatsu, C4742-95-12ERG) and 
analyzed with ImageJ software. The rate of pseudopod extension was calculated from the 
measured pseudopod lengths in time lapses. 
    
Rac activation assay 
To determine Rac-GTP levels in dHL-60 lysate, we used an absorbance-based 
(490 nm) Rac G-LISA kit (Cytoskeleton, Inc). dHL-60 cells were preincubated for 30 
min with ML-7 (25 μM), centrifuged for 5 min at 2,000 rpm at RT, resuspended in 
mHBSS (2 × 106 cells in 0.5 ml per condition), and stimulated or unstimulated with 100  
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nM fMLP. The reaction was stopped by adding 0.5 ml of 2× lysis buffer (provided with 
the kit) at 4°C. Subsequent steps were performed as described in the protocol attached to 
the kit. 
 
Measurement of polymerized actin 
The procedure for measuring polymerized actin has already been described 
(Fumagalli et al., 2007; Weiner et al., 2006). Briefly, cells (pretreated with or without 
ML-7, 30 min) were stimulated in mHBSS in suspension with 1 μM fMLP at RT. After 
fixation by 2% paraformaldehyde for 20 min at 4°C, cells were permeabilized with 0.2% 
Triton X-100 and stained with 0.2 µM rhodamine-phalloidin for 30 min on ice. Stained 
cells were resuspended in ice-cold PBS, and fluorescence was determined by flow 
cytometry with a BD Biosciences LSR II System. The mean fluorescence intensity of the 
cell population was determined. 
 
TIRF microscopy  
For TIRF microscopy, a TIRF module based on Axiovert 200M microscope 
(Zeiss) was used as a starting point. Before each experiment, 488-nm excitation light 
from a 100-mW multiline argon-ion laser (Zeiss) was aligned properly to create 
evanescent wave that can only excite the molecules within a layer of 100 nm above the 
cover glass. At the start of an experiment, a fibronectin-coated cover glass to which 
fluorescing cells were attached was placed on top of α Plan-Fluar 100x /1.45 oil objective 
lens. Microscopic images from the TIRF-illuminated cells were captured by AxioCam 
MR3 camera with an interval of 5 sec for indicated time. Exposure times for each image 
were typically less than 1 sec, and the TIRF laser was shuttered with a Uniblitz COM2 
shutter between exposures to minimize photodamage and photobleaching effects. 
 
Integrin activation assay 
A GST-tagged protein composed of 9th, 10th, and 11th fibronectin (FN) type III 
repeats (denoted as GST-FN III9-11) was used to monitor active α5β1 integrin as reported 
(Orr et al., 2006). The GST-FN fragment binds to unoccupied active integrins only. For 
adherent cells, integrin activation was determined as follows. After exposure to 
 33
chemoattractant or buffer, cells were fixed with paraformaldehyde (3.7%) and incubated 
with 50 µg/ml GST-FN III9-11 in PBS with 1 mM Ca2+/1 mM Mg2+ at 37°C for 30 min. 
Because the GST-FN fragment competes with the FN substrate to some extent, fixation 
of cells could eliminate interference from the FN substrate. After incubation with GST-
FN III9-11, Cells were gently washed, lysed in SDS sample buffer, and bound GST-FN 
III9-11 was blotted with an anti-GST antibody (1:1000). For immunofluorescence studies, 
after fixation, cells were incubated with GST-FN III9-11, followed by Alexa-conjugated 
secondary antibody. For suspended cells, a similar procedure was used, except that the 
cells were not fixed. A rabbit anti-α5 integrin antibody (1:1000) was used to assess the 
total level and localization of α5 integrin. 
 
Results 
MLCK is expressed and recruited to the leading edge in chemotaxing human neutrophils 
We next explored how localization-specific myosin II activity and tractions were 
controlled at the leading and the trailing edge. Earlier studies demonstrated that the 
spatial activation of myosin II at the trailing edge is dependent on p160-ROCK and 
necessary for tail retraction and de-adhesion (Wong et al., 2006; Xu et al., 2003). We thus 
sought to understand how myosin II was spatially activated at the leading edge in 
neutrophils. MLCK, a [Ca2+]/calmodulin-dependent kinase, phosphorylates MRLC and 
induces contractility in multiple processes (Kamm and Stull, 2001), including cell 
motility (Klemke et al., 1997; Wilson et al., 1991). To ask whether MLCK spatially 
regulated myosin II activation at the leading edge of neutrophils, we first examined its 
expression and subcellular localization.  
We examined the expression of MLCK in neutrophils. Western blotting indicated 
that both primary blood neutrophils and dHL-60 cells mainly expressed the ~130-kD 
short form of MLCK (Figure 4.1A); the 210-kD long form was nearly undetectable. This 
pattern was similar to that in human T lymphocytes (Smith et al., 2003), suggesting that 
predominance of the short MLCK form may be common to leukocytes.  
In non-stimulated neutrophils, MLCK was diffusely distributed in the cytosol, 
with some cortical localization (Figure 4.1B). When stimulated with fMLP, it was 
recruited to the leading edge of polarized cells and co-localized with F-actin (Figure 
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4.1B). The polarized recruitment was confirmed by ectopic expression of EGFP-tagged 
short form MLCK (sMLCK-EGFP) (in accordance with its expression in neutrophils). 
Upon uniform fMLP stimulation of dHL-60 cells, sMLCK-EGFP translocated from the 
cytosol to the plasma membrane within 30–45 sec (Figure 4.1C; Supplementary Movies 
S10 and S11). As cells polarized morphologically, typically by 2–3 min, sMLCK-EGFP 
was recruited to the leading edge. The asymmetric recruitment of MLCK was also seen in 
neutrophils polarizing and moving toward a point source of fMLP delivered by 
micropipette (Figure 4.1D). Furthermore, MLCK asymmetry was not caused by increased 
amounts of membrane in ruffles at the front, because the GFP-tagged N-terminal 
fragment of protein Lyn (24 amino acids; Lyn24-GFP) (Gupta and DeFranco, 2003), 
which associates with the plasma membranes via myristoylation and palmitoylation, was 
distributed uniformly around the plasma membranes (Figure 4.1E). The recruitment of 
MLCK to the leading edge is dependent upon actin binding via actin binding domain 
(ABD) near the N terminus of MLCK, as selective deletion of ABD in MLCK prevents 
translocation of the mutant MLCK molecule to the leading edge (data not shown).   
 
MLCK is required for the stable protrusion of the leading edge 
MLCK inhibition by a highly specific inhibitor ML-7 (25 M) impaired the 
stability of the leading edge and markedly reduced the speed of protrusion of dHL-60 
cells and primary neutrophils, as shown by experiments with the micropipette assay 
(Figure 4.2 and 4.3). Similar to myosin II inhibition, MLCK inhibition caused neutrophils 
to often retract their leading edges during migration (~ 0.4/min and 0.03/min for treated 
and untreated dHL-60 cells, respectively; ~ 0.7/min and 0.15/min for treated and 
untreated primary cells, respectively). However, unlike myosin II inhibition, MLCK 
inhibition failed to induce formation of stretched tails at the back of the cells (Fig. 4.2B 
and Fig. 4.3A).  
In circulating neutrophils 2-integrins are highly expressed and mediate the 
interactions with the endothelial cells. We thus assessed whether MLCK was also 
required for chemotaxis of neutrophils stimulated on ECM substrates for 2-integrins. 
Differentiated HL-60 cells, when stimulated by a fMLP gradient on fibrinogen or Inter-
Cellular Adhesion Molecule 1 (ICAM-1) (Figure 4.4 and data not shown), rapidly 
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polarized and migrated towards the source of the chemoatractants ((Figure 4.4).  ML-7 
treatment markedly impaired the leading edge stability of these cells (Figure 4.4). These 
results suggest that MLCK might play a conserved role in the regulation of neutrophil 
polarity and chemotaxis under different microenvironmental settings. 
The specificity of ML-7 for MLCK, instead of for other protein kinase including 
protein kinase A (PKA), was demonstrated at a similar concentration (Bain et al., 2003). 
Nevertheless to further confirm the specificity of MLCK, we used RNAi-mediated 
MLCK knockdown to deplete MLCK in dHL-60 cells. The Amaxa Necleofection System 
allowed us to deliver siRNAs into nearly all the cells after transfected and was used to 
transiently express siRNAs that selectively target MLCK (Figure 4.5A and 4.5B). The 
efficacy of the siRNAs to deplete MLCK was confirmed by assessing the level of 
endogenous MLCK, in the presence of either non-targeting siRNAs or siRNAs against 
MLCK (Figure 4.5A). MLCK depletion induced dHL-60 cells to exhibit defects in 
protrusion and migration similar to those caused by ML-7, whereas the non-targeting 
siRNAs exerted no effects (Figure 4.5C-4.5D).  
Notably, the migratory defects in cells treated with ML-7 or with MLCK depleted 
were more severe than mouse neutrophils deficient in MYLK, the 210 kD isoform of 
MLCK (Xu et al., 2008). When plated on fibrinogen and exposed to chemoattractants, the 
MYLK-deficient mouse neutrophils polarized normally, migrated faster than the wild-
type cells, but frequently changed direction. A possible explanation for the discrepancy is 
that ML-7 or siRNAs targets both isoforms of MLCK in dHL-60 cells while only the 210 
kD form is deleted in MYLK-deficient mouse neutrophils (Xu et al., 2008). 
We previously showed that the leading-edge activity is mediated by the frontness 
signaling pathway (Srinivasan et al., 2003; Wang et al., 2002; Xu et al., 2003). To 
provide a mechanistic explanation for the defects caused by MLCK inhibition and 
depletion, we assessed the effect of MLCK inhibition on frontness signals by monitoring 
the behavior of PH-AKT-GFP (GFP-tagged PH domain of the protein kinase Akt/PKB, 
readout for PI3Ps (Servant et al., 2000), PAK-PBD-YFP (yellow fluorescence protein-
tagged p21-binding domain of PAK, readout for Rac-GTP in dHL-60 cells (Srinivasan et 
al., 2003), and actin-YFP in living cells with or without MLCK inhibition. As described 
earlier, an fMLP gradient delivered by a micropipette induced cells to polarize and 
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migrate persistently towards the tip of the micropipette (Figure 4.6A, left panels). Upon 
fMLP stimulation, these fluorescent probes translocated from cytosol and accumulated at 
the leading edge of chemotaxing cells. The recruitment of PI3Ps, Rac-GTP and 
polymerized actin in pseudopods was robust and stable, as indicated by both the loss of 
cytosolic GFP (or YFP) signals after stimulation and their strong asymmetric localization 
at the neutrophil’s leading edge during migration. A quantitative analysis of the 
asymmetry in fluorescence intensity across the cells revealed a steep gradient of the 
fluorescent signal in untreated control cells (61, 85, and 67% decrease for PH-AKT-GFP, 
PAK-PBD-YFP and actin-YFP over a distance of 10 μm, respectively) (Figure 4.6B). In 
contrast, ML-7 treated cells under the same conditions exhibited poor leading edge 
recruitment of PH-AKT-GFP, PAK-PBD-YFP and actin-YFP, as reflected by much 
smaller gradients (21, 36, and 11%, respectively) (Figure 4.6A and 4.6B). Moreover, 
when compared with control cells, ML-7-treated cells exhibited a marked reduction (30–
50%) in the ratio of mean fluorescence intensity between the leading edge and cytosol 
(i.e., mean intensity at front/mean intensity at the back), again revealing an impaired 
asymmetric recruitment of the frontness markers (Figure 4.6C). The use of ratio of mean 
fluorescence intensity discounts the variations in the levels of fluorescence probes among 
cells and is thus more appropriate for assessing the relative accumulation of the 
fluorescent signals at the leading edge. Similar to ML-7 treatment, MLCK depletion also 
impaired the recruitment of the frontness markers (Figure 4.5E). 
To summarize, consistent with their effects on the leading edges, MLCK 
inhibition and depletion prevented accumulation of polymerized actin, 3’-phosphoinositol 
lipids (PI3Ps) and Rac-GTP at the leading edge. Actin polymers, PI3Ps and Rac-GTP are 
key components of the “frontness” pathway and play essential roles in establishing the 
leading edge during neutrophil chemotaxis (Srinivasan et al., 2003; Xu et al., 2003). Thus, 
our results show that MLCK is spatially recruited to the leading edge and is necessary for 
leading edge stability during neutrophil chemotaxis. 
 
MLCK regulates myosin activity at the leading edge 
MRLCs are the only known substrate for MLCK (Kamm and Stull, 2001). The 
asymmetric distribution of MLCK prompted us to ask whether this kinase would 
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selectively control the activity of myosin II at the leading edge. The ratio of mean 
immunofluorescence intensity of p[19]-MRLC between the leading and the trailing edge 
was ~25% lower in ML-7-treated dHL-60 cells than in the control cells (Figure 4.7A and 
4.7B), suggesting that MLCK inhibition impaired the accumulation of activated myosin 
II at the leading edge compared with the rest of the cell body. The use of ratio of mean 
fluorescence intensity discounts the variations in the levels of fluorescence probes among 
cells and is thus more appropriate for assessing the relative accumulation of the 
fluorescent signals. Furthermore, treatment with the p160-ROCK inhibitor Y-27632 
sharply reduced the distribution of phosphorylated myosin II at the trailing edge (Figure 
4.7A), in keeping with an earlier report (Xu et al., 2003). Inhibition of myosin II activity 
by ML-7 and Y-27632 was also demonstrated by western blotting of total p[19]-MRLC 
levels (Figure 4.7C). Intriguingly, both ML-7 and Y-27632 treatments increased the 
relative distribution of myosin IIA protein at the leading edge (Figure 4.7D; 24% and 
41%, respectively), probably due to the alterations in cytoskeletal organization. Taking 
into account the increased distribution of myosin IIA at the front, we inferred that ML-7 
caused >30% decrease in the relative level of activated myosin II (i.e., p[19]-MRLC/total 
myosin IIA) at the leading edge.  
 
MLCK-mediated actomyosin contractility regulates traction in neutrophil chemotaxis 
Inhibiting or depleting MLCK in neutrophils markedly reduced the tractions at the 
leading edge (Figure 4.8A and 4.8B; Supplementary Movie S12) in cells migrating on the 
substrate with 3.5 kPa of stiffness (Table 2.1). Interestingly, the same treatments also 
reduced the tractions at the trailing edge (Figure 4.8A and 4.8B) (Table 2.1). Furthermore, 
MLCK inhibition (or depletion) abolished the periodic pattern of tractions at both the 
leading and the trailing edge in dHL-60 cells and primary neutrophils (Figure 4.8B-C, 
Figure 4.9A-B and Figure 4.10A). Because the tractions in MLCK-inhibited/depleted 
cells were reduced at both edges and were no longer periodic. This finding suggested 
coordination and coupling of tractions at the front and the back under this matrix stiffness. 
In keeping with this notion, treatment of cells with Y-27632 also substantially reduced 
the tractions and prevented the periodic oscillations at both the leading and the trailing 
edge (Figure 4D-4F, Figure 4.9C and Figure 4.10B) (Table 2.1).  
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It was recently documented that the chemotactic behaviors of neutrophils were 
influenced by substrate stiffness (Oakes et al., 2009). To investigate whether MLCK 
played a more conserved role in the regulation of tractions, we assessed the effect of 
MLCK inhibition in neutrophils migrating on a stiffer substrate (100 kPa). Primary 
neutrophils migrating towards a fMLP-containing micropipette exerted higher tractions 
under this condition, in keeping with the previous report (Oakes et al., 2009) (Table 2.1). 
Tractions at the leading and the trailing edge both demonstrated periodicity (4.7 ±1.5 sec 
and 4.7 ±1.0 sec, respectively) and were out of phase by 1.0±0.3 sec (Figure 4.11A and 
4.11B). Myosin II inhibition, as expected, markedly reduced the levels and prevented the 
periodicity of traction at both edges (Figure 4.12A). MLCK inhibition exerted very 
similar effects on tractions to blebbistatin treatment (Fig. 4.12B). Intriguingly, although 
treatment of cells with Y-27632 reduced tractions by 40-45% (Table 2.1), the cells 
nevertheless exhibited periodic tractions at both edges (4.7±0.9 sec and 5.0±1.3 sec, 
respectively) (Figure 4.11C), with a lag of 0.90 ± 0.33 sec (Figure 4.11D). These results 
suggest a differential regulatory pattern of tractions in cells migrating on the stiffer 
substrate. 
 
MLCK-driven contractile force controls leading edge adhesion by activating 1-
integrin 
How does MLCK-mediated myosin contractility control leading-edge stability in 
neutrophils? During migration protrusion and adhesion of the leading edge are tightly 
coupled (Ridley et al., 2003). Cell adhesion sites are required to stabilize leading edges 
and promote cell polarity in cells migrating on flat surfaces (Ridley et al., 2003). MLCK-
mediated myosin II contractility may be necessary for leading edge protrusion. 
Alternatively, the defects of MLCK inhibition (or depletion) on neutrophil polarity can be 
interpreted as the inability of the cells to attach their protrusive pseudopods, resulting in 
unstable and poorly developed leading edges. Indeed, blocking leading edge adhesion of 
neutrophils with RGD peptides targeting 5β1integrin, the main fibronectin receptors in 
neutrophils, caused defects highly reminiscent of those induced by MLCK inhibition, as 
discussed in detail below.  
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MLCK-inhibited fibroblasts exhibit defects in assembly (Totsukawa et al., 2004b) 
or turnover (Webb et al., 2004) of focal adhesions. Cell adhesion sites are required to 
stabilize leading edges and promote cell polarity (Ridley et al., 2003). To assess the role 
of adhesion in regulating neutrophil polarity during chemotaxis, we plated dHL-60 cells 
on fibronectin and then treated them with a soluble RGD peptide that inhibits binding of 
5β1-integrin to fibronectin (5β1-integrins are the main fibronectin receptors in 
neutrophils (Staffan Johansson, 1997)) before fMLP stimulation. This procedure allowed 
us to selectively prevent fMLP-induced de novo adhesion. An RAD peptide was used as 
a negative control. With a point source of fMLP in the presence of RAD peptide, dHL-60 
cells migrated to the pipet tip and maintained a highly polarized morphology with well-
developed pseudopods (Figure 4.13A and 4.13B). In contrast, cells treated with the RGD 
peptide only transiently polarized in response to fMLP, with much smaller and less stable 
leading edges that often retracted after protrusion, resulting in a less polarized, slowly 
migrating cell (Figure 4.13A-C). Thus, blocking cell adhesion caused defects that 
mirrored those caused by MLCK inhibition (Figure 4.2B). 
MLCK inhibition markedly impaired neutrophil adhesion. First, experiments with 
a commonly used cell plating assay demonstrated that MLCK inhibition compromised 
adhesion of dHL-60 cells to fibronectin (Figure 4.14A). Interestingly, MLCK inhibition 
specifically prevented cell adhesion induced by fMLP, because ML-7 had little effect on 
cell adhesion to fibronectin in the absence of fMLP stimulation (Figure 4.14A). To 
further analyze adhesion at the single cell level, we used total internal reflection 
fluorescence (TIRF) microscopy in dHL-60 cells expressing GFP-tagged 5integrin. 
The goal of this experiment was to assess whether MLCK inhibition impaired 
5β1integrin-mediated leading edge attachment. The evanescent wave causes excitation 
of fluorescent molecules in an optical section (<100 nm) without exciting molecules 
throughout the specimen and allows visualization of signaling activity in living cells in 
contact with the coverglass (substrate). TIRF microscopy analysis suggested that in 
response to a point source of fMLP gradient, neutrophils extended a protrusive leading 
edge and established contact with the fibronectin substrate, as indicated by the emergence 
of GFP fluorescence at the leading edge (Figure 4.14C). In addition, de-adhesion and 
retraction of trailing edge was apparent, as suggested by the disappearance of GFP 
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fluorescence at the trailing edge of migrating cells (Figure 4.14C). MLCK inhibition 
markedly impaired leading edge attachment, as suggested by the absence or reduction of 
fluorescent signals of GFP-5 integrin at the leading edge (Figure 4.14D). We analyzed 
attachment quantitatively in control and MLCK-inhibited cells by measuring TIRF 
signals within the leading edge (as defined by DIC images) (Figure 4.14B). This analysis 
suggested that MLCK inhibition reduced leading edge adhesion by 78% (Figure 4.14B). 
In contrast, the same treatment only slightly altered attachment of the area outside the 
leading edge (denoted as Cell body) (Figure 4.14B: right panel). Thus, MLCK inhibition 
impaired leading edge adhesion. However, these results alone could not distinguish 
whether MLCK mediates leading edge protrusion or adhesion, as discussed above. As 
expected, cells treated with Y-27632 exhibited long stretched tail that failed to retract 
properly, while cells with blebbistatin treatment showed defects in both leading edge 
attachment and tail retraction (Figure 4.14E-F).  
We next asked whether MLCK was necessary for leading edge protrusion. We 
took advantage of a feature of neutrophils: their ability to polarize when stimulated with 
chemoattractants, even in suspension. When exposed to fMLP, neutrophils in suspension 
quickly (within 1–2 min) establish a morphological leading edge (Zhelev et al., 2004). 
The leading edge does not persist and retracts after stimulation (Fechheimer and Zigmond, 
1983; Sklar et al., 1985; Wang et al., 2002; Ydrenius et al., 1997). Attractant stimulation 
of neutrophils in suspension also suffices to lead to accumulation of polymerized actin, 
PI3Ps and Rac-GTP, albeit transiently, consistent with the morphological response 
(Srinivasan et al., 2003; Wang et al., 2002; Xu et al., 2003). When held with a pipette, 
dHL-60 cells responded to a gradient of fMLP from an adjacent pipette by extending a 
leading edge (Figure 4.15A). The leading edge continued to grow and then retracted. 
Cells treated with ML-7 exhibited no detectable defects in the protrusive behavior and 
dynamics when stimulated with the fMLP gradient (Figure 4.15A and 4.15B). We next 
measured the level of polymerized actin, Rac-GTP and phospho-Akt (activated Akt, 
readout for PI3Ps) (Wang et al., 2002; Xu et al., 2003) with or without fMLP stimulation. 
Consistent with previous findings (Srinivasan et al., 2003; Wang et al., 2002; Xu et al., 
2003), fMLP addition induced a rapid and transient accumulation of polymerized actin, 
phospho-Akt and Rac-GTP in neutrophils in suspension, which peaked at 30─60 sec after 
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stimulation (Figure 4.15C-E). Treatment with ML-7 failed to prevent any of these 
frontness markers in cells exposed to fMLP in suspension (Figure 4.15C-E). Therefore, 
MLCK is not required for protrusion per se but appears to regulate leading edge adhesion. 
In addition, because MLCK inhibition/depletion impaired the leading-edge accumulation 
of PI3Ps, Rac-GTP and actin polymers in adherent cells (Figure 4.5E and 4.6), these 
results imply that cell adhesion is necessary for the stability of the frontness signals. 
Integrin activation refers to a switch from a low-affinity to a high-affinity state of 
ligand binding. Integrin activation is the key step for cell adhesion to the ECM (Hynes, 
2002). To explain how MLCK controls cell adhesion during neutrophil chemotaxis, we 
tested if MLCK is involved in integrin activation during chemotaxis. We assessed the 
localization and expression of activated 51-integrin with a GST-tagged protein 
containing the 9th to 11th fibronectin type III repeats (GST–FN III9-11), which specifically 
binds active 51-integrin (Orr et al., 2006). While total 51-integrin (as detected by 
anti-5-integrin antibody) was found evenly distributed throughout the cell, activated 
 integrin was enriched at the leading edge of polarized dHL-60 cells [Figure 4.16A; 
A focal plane from the confocal microscopy analysis is shown]. Consistently, the line 
profile of the polarized cell exhibited highest level of GST–FN III9-11 binding at the 
leading edge (Figure 4.16A). MLCK inhibition caused the level of active 51-integrin 
to markedly reduce at the leading edge, whereas the localization pattern of total 51-
integrin remained unchanged (Figure 4.16B). Incubation of cells with GST alone failed to 
produce fluorescent signals (Figure 4.16C). These results suggest that MLCK controls 
51-integrin activity at the neutrophil’s leading edge.  
We next assessed the level of activated 51-integrin in cells with or without 
MLCK inhibition biochemically. As shown in Figure 4.16D, ML-7 exerted little effect on 
fMLP-induced activation in neutrophils in suspension, indicating that MLCK activity is 
not necessary for the inside-out activation of 51-integrin by fMLP (i.e., in the absence 
of adhesion to ECM). However, the same treatment prevented 51-integrin activation 
when cells were attached to the fibronectin substrate (Figure 4.16E), demonstrating that 
MLCK is necessary for 51-integrin activation in adherent cells. The dependence of 
MLCK-mediated integrin activity on cell-ECM adhesion suggested that tractions may 
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play a special role in this regulation. Traction-induced cytoskeletal tension could activate 
integrin mechanically, as discussed in the next chapter.  
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Figure 4.1 
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Figure 4.1 (cont.) Short form of MLCK is expressed and recruited to the leading 
edge in chemotaxing neutrophils  
(A) Western blotting of primary human neutrophils and dHL-60 cells with mAbs specific 
for MLCK. α-tubulin was used as a loading control. (B) dHL-60 cells plated on 
fibronectin-coated coverslips were stimulated for 2 min with 1 µM fMLP, fixed with 
3.7 % paraformaldehyde and stained with a specific anti-MLCK antibody (red) and Alexa 
fluor 488-conjugated phalloidin (green). The polarized distribution of endogenous MLCK 
was observed in 188 out of 269 polarized cells. (C) dHL-60 cells were transfected with 
sMLCK-EGFP and exposed for the indicated times to the uniform concentration of fMLP 
(1 µM). sMLCK-EGFP fluorescence and the corresponding DIC images are shown. 
Arrows point to the recruitment of sMLCK-EGFP. n = 31 cells. (D) dHL-60 cells were 
transfected with sMLCK-EGFP and exposed for the indicated times to 10 µM fMLP from 
a micropipette. sMLCK-EGFP fluorescence and corresponding DIC images are shown. n 
> 15 cells. Bars = 10 µm. Arrows point to the recruitment of sMLCK-EGFP. Movie of 
the cells in (D) is available (Supplementary Movies S10 and S11). (E) dHL-60 cells were 
transfected with Lyn24-GFP and stimulated by a micropipette containing 10 µM fMLP 
for the indicated times. GFP fluorescence and the corresponding DIC images are shown. 
The arrows points to a migrating cell with uniform distribution of Lyn24-GFP. Bar, 10 
µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 45
 
 
 
 
 
 
Figure 4.2 MLCK inhibition reduces stability of the leading edge in dHL-60 cells 
(A) dHL-60 cell treated with ML-7 (25 µM, 30 min) was exposed to a point source of 10 
µM fMLP for the times indicated (bottom panel). The cell fails to migrate to the 
micropipette and shows poorly developed pseudopod (white arrow). Untreated dHL-60 
cell (top panel) with well-developed, stable pseudopod is shown. Bars=10 µm. (B) DIC 
kymographs (left) of a dHL-60, untreated or treated with ML-7, migrating toward an 
fMLP (10 µM)-containing micropipette. The dotted rectangles indicate the regions of the 
cell used to generate the kymographs (prior to fMLP stimulation). The actual lengths of 
the rectangles are 20 µm in the direction of the arrow. Left panel: scale bar=1 µm. Right 
panel: scale bars = 5 µm. Arrows indicate the direction of protrusion. 5 min of migration 
was recorded. The speed of leading-edge protrusion was calculated based on the 
kymographs (right). The values are means ± SEM (n = 34 for control, and 32 for cells 
treated with ML-7). Asterisks indicate that the value for cells with ML-7 treatment differs 
from the corresponding control by P < 0.0001. 
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Figure 4.3 MLCK inhibition reduces stability of the leading edge in primary 
neutrophils 
(A) Primary neutrophils were pretreated with or without ML-7 (25 μM, 30 min) prior to 
the exposure to an attractant supplied by a micropipette containing 10 μM fMLP. The 
four images in each row show the positions of representative cells (each identified with a 
superimposed letter) after the indicated times of exposure to fMLP. The white arrow 
points to the poorly-developed leading edge. Scale bar, 10 µm. (B and C) Speed of 
protrusion (B) and retraction frequency (C) of the leading edge in primary neutrophils 
responding to a gradient of fMLP delivered by a micropipette. Cells were pretreated with 
or without ML-7. The value are means ± SEM (n = 21 for control, 22 for cells treated 
with ML-7). Student t tests compared data between experimental groups. Results 
significantly different from those of control are indicated by asterisks (**; p < 0.001). 
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Figure 4.4 MLCK inhibition impairs stability of the leading edge in neutrophils 
crawling on fibrinogen 
(A) Before exposure to attractant supplied by a micropipette containing 10 μM fMLP, 
cells plated on fibrinogen (denoted as FG) were not pretreated (control) or pretreated with 
ML-7 (25 µM, 30 min). The three images in each row show the positions of individual 
cells (each identified with a superimposed letter) after the indicated times of exposure to 
fMLP. The yellow arrows point to the position of micropipettes, which are out of focus. 
Scale bar, 10 µm. (B and C) Speed of protrusion (B) and retraction frequency (C) of the 
leading edge in cells on fibrinogen responding to a gradient of fMLP delivered by a 
micropipette. dHL-60 cells were not pretreated (control) or pretreated with ML-7. The 
value are means ± SEM (n = 22 for control, 21 for cells treated with ML-7. Student t tests 
compared data between experimental groups. Asterisks indicate that the value for cells 
with ML-7 treatment differs from the corresponding control by P < 0.0001. 
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Figure 4.5 MLCK depletion disrupts the stability of the leading edge in neutrophils  
(A) dHL-60 cells were transfected with pooled siRNAs which are specifically targeting 
human MLCK or non-targeting and blotted for MLCK (left panel). α-tubulin is a loading 
control. Right panel: relative level of endogenous MLCK is measured after transfecting 
each siRNA constructs. Values are means ± SEM (n = 3). Results significantly different 
from those of control are indicated by asterisks (*, p < 0.05). (B) dHL-60 cells were co-
transfected with siGLO Red and pooled siRNAs that are either non-targeting or 
specifically targeting human MLCK at the ratio of 1:5. 48 hrs after transfection, pictures 
were taken to check the transfection efficiency of siRNAs into dHL-60 cells. Only 
images of cells co-transfected with siGLO and non-targeting siRNAs are shown. Bar, 10 
µm. (C and D) dHL-60 cells which were transfected with pooled siRNAs that are either 
non-targeting or specifically targeting human MLCK were exposed to a chemotactic 
gradient delivered from a micropipette containing 10 µM fMLP for 5 min. Speed of 
protrusion (C) and retraction frequency (D) of the leading edge in cells responding to the 
gradient throughout the observed time period. The results are shown in the graph (n = 49 
for non-targeting siRNA-transfected cells, 56 for MLCK-specific siRNA-transfected 
cells). Results significantly different from those of control are indicated by asterisks (*, p 
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Figure 4.5 (cont.) < 0.001; **; p < 0.0001). MLCK depletion caused similar protrusion 
and migration defects when cells were stimulated on fibrinogen (data not shown). (E) 
dHL-60 cells co-transfected with actin-YFP and siRNAs (either non-targeting or 
specifically targeting human MLCK) were exposed to a chemotactic gradient delivered 
from a micropipette containing 10 µM fMLP for the times indicated. Fluorescence 
images of actin-YFP and the corresponding DIC images are shown. (n = 14 for non-
targeting siRNA-transfected cells, 11 for MLCK-specific siRNA-transfected cells). All 
scale bars = 10 µm. 
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Figure 4.6 MLCK inhibition impairs stable accumulation of frontness signals at the 
leading edge 
(A) dHL-60 cells transfected with actin-YFP (top), PAK-PBD-YFP (middle), or PH-
AKT-GFP (bottom) and pretreated with or without ML-7 (25 µM, 30 min) were exposed 
to an fMLP (10 µM)-containing micropipette and allowed to migrate for the times 
indicated. Fluorescence of each probe and the corresponding DIC images are shown. Bar, 
10 µm. (B) Spatial distribution and line profiles of actin-YFP, PAK-PBD-YFP, and PH-
AKT-GFP gradients in dHL-60 cells exposed to fMLP (10 µM), delivered from a 
micropipette (white dot indicates the beginning of the measurement) for ~ 240 s. Cells 
were not pretreated (top) or were pretreated with ML-7 (bottom). A graph below each 
image plots fluorescence intensity of each probe (y axis) versus distance (x axis) for the 
corresponding cell. (C) Relative accumulation of actin-YFP, PAK-PBD-YFP, and PH-
AKT-GFP at the leading edge of dHL-60 cells exposed to fMLP (10 µM), delivered from 
a micropipette. Leading edge (L) in fluorescence image was demarcated by the 
corresponding DIC image and the rest of the cell was defined as cell body (C). Cells were 
pretreated with or without ML-7. For control cells, 3 min after the attractant exposure 
was chosen for analysis. For treated cells, a time point when the pseudopod extension is 
at its peak was selected. Each bar in the graph below represents the ratio of mean 
fluorescence intensity between the leading edge and cell body. Values are normalized to 
the ratio of mean fluorescence intensity in control cells (=100%) and are means ± SEM (n 
is shown within each bar). Results significantly different from those of control are 
indicated by asterisks (*, p < 0.001; **; p < 0.0001). 
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Figure 4.7 MLCK inhibition/depletion impairs myosin II activity at the leading edge 
(A) dHL-60 cells not pretreated or pretreated with ML-7 (25 µM, 30 min) or Y-27632 
(30 µM, 30 min) were stimulated for 3 min by a uniform concentration of 1 µM fMLP. 
Cells were fixed with 3.7 % paraformaldehyde and stained with the anti-MHCIIA 
antibody, anti-p[Ser19]MRLC antibody, and rhodamine-conjugated phalloidin. The 
corresponding DIC images are also shown. Bar, 10 m. (B) The distribution of 
p[Ser19]MRLC in dHL-60 cells with or without ML-7 treatment was analyzed. The mean 
fluorescence of p[Ser19]MRLC staining at the leading and the trailing edge of cells was 
determined using Image J software, and the ratios between the leading and the trailing 
edge (i.e., mean fluorescence intensity at the leading edge/mean fluorescence intensity at 
the trailing edge) are shown. Values were normalized to the ratio (=100%) in control cells 
and are means±SEM (n = 40 for control, and 30 for cells treated with ML-7). Student t 
tests compared data between experimental groups. Results significantly different from 
those of control are indicated by asterisks (*; p < 0.001). (C) Western blot of 
p[Ser19]MRLC. dHL-60 Cells were pretreated with no inhibitors, ML-7 (25 M, 30 min 
pretreatment), or Y-276322 (30 M, 30 min) before exposure to fMLP for 2 min in 
suspension. A typical blot is shown in the top panel, and quantification of blots from four 
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Figure 4.7 (cont.) separate experiments is shown in the bottom panel. Each bar 
represents the mean±SEM (error bars). All values were normalized to the signal (=100%) 
detected without the inhibitors. Asterisks indicate that the value for cells treated with M-7 
or Y-27632 differs statistically from the control (*, p<0.01; **, p<0.001). Total MHCIIA 
levels were unaltered with the treatments and used for equal loading in the different lanes. 
(D) The distribution of total MHCIIA in control dHL-60 cells and cells pretreated with 
ML-7 or Y-27632 was analyzed. The mean fluorescence of MHCIIA staining at leading 
and trailing edges was assessed by Image J software, and the ratios between leading and 
trailing edges are shown. Values were normalized to the ratio (=100%) in control cells 
and are means ± SEM (n = 40 for control, 30 for cells treated with ML-7, and 25 for cells 
treated with Y-27632). Results significantly different from those of control are indicated 
by asterisks (*, p < 0.05; **; p < 0.001).  
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Figure 4.8 
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Figure 4.8 (cont.) Localization-specific myosin activities are necessary for tractions 
in neutrophils 
(A) dHL-60 cells depleted of MLCK were allowed to migrate toward chemoattractant-
containing micropipette (fMLP, 10 µM) on a fibronectin-coated elastic polyacrylamide 
gel for the indicated times. Traction maps of the cell are shown. Pseudocolor bar 
representing tractions is given in Pascal (Pa). Scale bar = 5 µm. The leading edge (within 
the first 2.2 m of the cell) is marked by a white line (see Supplementary Methods). The 
image series shows part (5.6 sec) of the whole migratory response. Cells treated with 
ML-7 exhibited similar responses. Cells treated with ML-7 or MLCK-specific siRNAs 
migrated at 1.1 m/min on the elastic gel. The movie of the cell in (A) is available in the 
Appendix. (B) Time series of traction maps from (A) (with five additional time points) 
was analyzed by a customized MATLAB program to determine the average traction force 
in both leading (front) and trailing edges (back) of the cells in a time-dependent manner. 
The graph shows part (~9.6 sec) of the whole migratory response. x axis indicates time in 
sec. y axis is in Pascal (Pa). (C) PSD plots of tractions at the leading (left panel) and the 
trailing edge (right panel) of a migratory cell with MLCK depleted. The whole migratory 
response was analyzed. y axis represents the power spectral density normalized to the 
highest peak value (=1). x axis shows the oscillation frequency (Hz) (top) or period (s) 
(bottom). Cells pretreated with ML-7 exhibited similar response (not shown). 10 cells 
were analyzed, and a representative cell is shown. Additional plots for ML-7 treatment 
and MLCK depletion are shown in Figure 4.9A and Figure 4.9B. (D) dHL-60 cells 
pretreated with Y-27632 (30 m, 30 min) were allowed to migrate toward 
chemoattractant-containing micropipette (fMLP, 10 µM) on a fibronectin-coated elastic 
polyacrylamide gel for the indicated times. Traction force maps of the cell are shown. 
Pseudocolor bar representing traction force is given in Pascal (Pa). Scale bar = 10 µm. 
The leading edge (within the first 3 m of the cell) is marked by a white line (see 
Materials and Methods). The image series shows part (5.6 sec) of the whole migratory 
response. (E) Time series of traction force maps from (D) (with five additional time 
points) was analyzed by a customized MATLAB program to determine the average 
traction force in both leading (front) and trailing edges (back) of the cells in a time-
dependent manner. The graph shows part (~9.6 sec) of the whole migratory response. x 
axis indicates time in sec. y axis is in Pascal (Pa). (F) PSD plots of tractions at the leading 
(left panel) and the trailing edge (right panel) of a migratory cell pretreated with Y-27632. 
The whole migratory response was analyzed. y axis represents the power spectral density 
normalized to the highest peak value (=1). x axis shows the oscillation frequency (Hz) 
(top) or period (s) (bottom). 8 cells were analyzed, and a representative cell is shown. 
Additional plots are shown in Figure 4.9C. 
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Figure 4.9 Inhibition (or depletion) of MLCK or ROCK abolishes periodicity of 
traction in dHL-60 cells  
PSD plots of tractions at the leading (left panel) and the trailing edge (right panel) of 
three dHL-60 cells pretreated with ML-7 (25 µM, 30 min) (A), with MLCK depleted (B) 
and pretreated with Y-27632 (100 µM, 30 min) (C). Tractions values from three cells 
were analyzed and combined in one plot. See Figure 4.8 legends for more details. 
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Figure 4.10 Inhibition of MLCK or ROCK abolishes periodicity of traction in 
primary neutrophils  
PSD plots of tractions at the leading (left panel) and the trailing edge (right panel) of 
primary neutrophils pretreated with ML-7 (25 µM, 30 min) (A), or Y-27632 (100 µM, 30 
min) (B). 6 cells were analyzed for each treatment, and a representative cell is shown. 
Cells were on a substrate of 3.5 kPa stiffness. 
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Figure 4.11 
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Figure 4.11 (cont.) The pattern and regulation of tractions in neutrophils on a stiffer 
substrate 
(A) PSD plots of tractions at the leading (left panel) and the trailing edge (right panel) of 
a migratory primary neutrophil. PSD plots were generated based on the results from 
Fourier analysis of the traction values. y axis represents the power spectral density 
normalized to the highest peak value (=1). x axis shows the oscillation frequency (Hz) 
(top) or period (s) (bottom). Primary cells were allowed to migrate toward 
chemoattractant-containing micropipette (fMLP, 10 µM) on a fibronectin-coated 
polyacrylamide gel (100 kPa) for 4-5 min. 6 cells were analyzed, and a representative cell 
is shown. (B) Left panel: Cross correlation between tractions at the leading and the 
trailing edge against time offset during migration for individual primary neutrophils. 
Dotted lines indicate zero offset. Data from 3 representative cells are shown. Time bar = 
24 s. Right panel: Summary of time offsets between leading edges and trailing edges 
(n=6 cells) in primary cells. (C) PSD plots of tractions at the leading (left panel) and the 
trailing edge (right panel) of a migratory primary neutrophil pretreated with Y-27632 (30 
M, 30 min). PSD plots were generated based on the results from Fourier analysis of the 
traction values. y axis represents the power spectral density normalized to the highest 
peak value (=1). x axis shows the oscillation frequency (Hz) (top) or period (s) (bottom). 
Cells were allowed to migrate toward chemoattractant-containing micropipette (fMLP, 10 
µM) on a fibronectin-coated polyacrylamide gel (100 kPa) for 4-5 min. 6 cells were 
analyzed, and a representative cell is shown. (D) Left panel: Cross correlation between 
tractions at the leading and the trailing edge against time offset during migration for 
individual Y-27632-treated primary neutrophils. Dotted lines indicate zero offset. Data 
from 3 representative cells are shown. Time bar = 24 s. Right panel: Summary of time 
offsets between leading edges and trailing edges (n=6 cells) in Y-27632-treated primary 
cells. 
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Figure 4.12 Inhibition of myosin II or MLCK abolishes the periodicity of traction in 
primary neutrophils on a stiffer substrate 
PSD plots of tractions at the leading (left panel) and the trailing edge (right panel) of a 
migratory primary neutrophil pretreated with ML-7 (25 µM, 30 min) (A) or Blebbistatin 
(100 µM, 30 min) (B). Cells were allowed to migrate toward chemoattractant-containing 
micropipette (fMLP, 10 µM) on a fibronectin-coated polyacrylamide gel (100 kPa) for 4-
5 min. 6 cells were analyzed for each condition, and a representative cell is shown. 
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Figure 4.13 Inhibition of adhesion prevents leading-edge establishment and stability 
(A) A dHL-60 cell bathed in RGD peptides (50 µg/ml) was exposed to a point source of 
fMLP (10 µM in the micropipette) for the times indicated (bottom). The cell fails to 
migrate to the micropipette and shows poorly developed pseudopod. Compare this 
response to that of a dHL-60 cell (top) in RAD (50 µg/ml)-containing buffer which 
shows well-developed, stable pseudopod. (B) Higher magnification DIC images of two 
migrating cells show characteristic shapes of the leading edge either with RAD treatment 
(left) or with RGD treatment (right). (C) dHL-60 cells bathed in either RAD or RGD 
peptides (50 µg/ml) were exposed to a chemotactic gradient delivered from a 
micropipette containing 10 µM fMLP for 10 min. The cells were assessed for their ability 
to establish or maintain polarity toward the micropipette throughout the observed time 
period. The result is shown in the graph (n = 43 for RAD-treated cells, 48 for RGD-
treated cells). All scale bars = 10 µm.  
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Figure 4.14 MLCK inhibition impairs attachment of the leading edge in neutrophils  
(A) dHL-60 cells pretreated with (25 µM, 30 min) or without ML-7 were not stimulated 
or stimulated in suspension by 100 nM fMLP and allowed to adhere to fibronectin-coated 
surface for 30 min, after which the degree of cell adhesion was assessed. Values were 
normalized to adhesion in control cells (=100%) with fMLP and are means±SEM (n=4). 
Results significantly different from those of control are indicated by asterisks (*, p < 
0.001). (B) Assessment of adhesion area in leading edge and cell body in control and 
ML-7-treated cells transfected with EGFP-α5-integrin and exposed to a point source of 
10 µM fMLP. Cell images were from Figure 4.14 (C) and (D). Left panel: The time point 
at which leading edge protrusion of individual cell‘s was maximal was selected for 
analysis. Leading edge (denoted as “L”) in TIRF image was demarcated by the 
corresponding DIC image, and the rest of the cell was defined as Cell body (denoted as 
“C”). Right panel: fluorescence intensities of the leading edge and the cell body in the 
TIRF images of control and ML-7-treated cells were determined with Image J, and the 
resulting values were used to quantify cell attachment of the  both leading edge and the 
cell body. The plot shows the relative values in each region compared to control (=100%) 
in the presence of fMLP stimulation. Values are means±SEM (n=13 for control, 11 for 
cells treated with ML-7). Results significantly different from those of control are  
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Figure 4.14 (cont.) indicated by asterisks (*; p < 0.0001). (C-F) dHL-60 cells were 
transfected with EGFP-α5-integrin and exposed to a point source of 10 µM fMLP (from 
micropipette) for the indicated times. TIRF (488 nm) and the corresponding DIC images 
are shown. Cells were not pretreated (C) pretreated with ML-7 (D), Blebbistatin (E) and 
Y-27632 (F). Leading-edge attachment of control cells was indicated by the GFP 
fluorescence; nearly no signals were detected at the leading edges in cells treated with 
ML-7 or Blebbistatin. Leading edges in the TIRF images are marked by white dotted 
lines. White arrows indicate the direction of chemoattractant gradient. Black arrows point 
to the long stretched trailing edges. 
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Figure 4.15 MLCK is not required for protrusion per se 
(A) A single, non-stimulated dHL-60 cell, pretreated with or without ML-7 (25 µM, 30 
min), was held with a pipette and exposed to a gradient from 10 µM fMLP from a 
delivery pipette. Before exposure to fMLP, the cell was spherical (i). Within 20 s, a 
pseudopod started to grow (ii). The pseudopod extended until a maximal length was 
reached (iii and iv), and then it started to retract (v and vi). Bar, 10 µm. (B) The growth 
of pseudopod as a function of time. Pseudopod formation was stimulated with delivery of 
10 µM fMLP from a pipette as shown in (A). Chemoattractant delivery started at time 0. 
Values are means±SEM (n=6). (C) Quantification of F-actin polymerization. Cells 
pretreated with or without ML-7 were stimulated with fMLP (1 µM) for various times in 
suspension and fixed for staining with rhodamine-phalloidin. Fluorescence in stained 
cells was determined by flow cytometry. Values are means ± SEM (n = 4). (D) 
Quantification of Rac-GTP in dHL-60 cells with or with ML-7 treatment. Cells were 
pretreated with ML-7, stimulated with fMLP (1 µM) for times indicated and lysed. The 
level of Rac-GTP was determined by the use of an absorbance-based Rac G-LISA kit. 
The y axis represents relative absorbance normalized to the signal (=1) detected in the 
control cells without ML-7 treatment. Each bar represents the mean±SEM (error bars) (n 
=4). (E) dHL-60 cells pretreated with or without ML-7 were stimulated for indicated 
times in suspension and lysed. Akt phosphorylation (Ser473) was assessed by western 
blotting. Values are normalized to the level in control cells without fMLP stimulation 
(=1) and are means±SEM (n=8). Representative blots for phospho- and total Akt are 
shown.  
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Figure 4.16 
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Figure 4.16 (cont.) MLCK controls neutrophil adhesion and integrin activation 
(A, B) Upper panel: Localization of activated α5β1 integrins in polarized neutrophils 
pretreated with or without ML-7 (25 M, 30 min). dHL-60 cells pretreated with or 
without ML-7 were plated on fibronectin-coated coverslips and stimulated for 3 min by 1 
µM fMLP. After washing, cells were fixed with 3.7 % paraformaldehyde, incubated with 
GST-FN III9-11 (50 µg/ml) for 15 min at 37°C, and stained with an anti-GST antibody and 
anti-5-integrin antibody. Fluorescent (red: 5-integrin; green: activated integrin) and 
phase contrast images were collected by using confocal fluorescence microscopy. The 
images of a representative cell for each condition are shown (n=20 for control, n=17 for 
ML-7 treatment). Arrows indicate the leading edge. White line indicates the path along 
which line profile was obtained. The weak signals for GST-FN binding may be attributed 
to the relative low levels of activated -integrin in the cells. Bar, 10 m. Lower 
panel: Line profiles of GST-FN III9-11 and 5-integrin fluorescence in cells shown in the 
upper panel. The graphs plot fluorescence intensity of each protein (y axis; in arbitrary 
unit) versus distance (x axis in pixels) along the white line on the phase contrast image of 
the cells. (C) dHL-60 cells were fixed, incubated with GST, fixed and stained with an 
anti-GST antibody and anti-5-integrin antibody. The procedure was performed as 
described in Figure 4.16A-B, except that GST was used. The yellow arrow points to the 
leading edge.  Bar, 10 µm. (D, E) Levels of activated α5β1 integrins in cells with or 
without ML-7 treatment. dHL-60 cells pretreated with or without ML-7 were stimulated 
by a uniform concentration of fMLP (100 nM) in either suspension (D) or adhesion 
conditions (E). After brief washing, cells were incubated with GST-FN III9-11 (50 µg/ml) 
for 30 min at 37°C, washed and lysed. The lysates were probed with an anti-GST 
antibody. α5-integrin was used as a loading control. A typical blot is shown on the left. 
The right panel shows quantification of blots from four separate experiments. The y axis 
represents relative intensities (measured with Image J) with values normalized to the 
signal (=1) detected in the control cells without ML-7 treatment. Each bar represents the 
means±SEM (n=4). Results significantly different from those of cells without fMLP 
stimulation are indicated by asterisks (*, p < 0.0001; **; p < 0.001). 
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CHAPTER 5 
 
DISCUSSION 
 
As discussed in the Introduction, traction is essential in cell migration in that it 
provides driving force for forward movement of cells and yet, there is a paucity of 
information on the spatiotemporal pattern, regulation and function of traction during 
neutrophil chemotaxis. Employing traction force microscopy at a much higher temporal 
resolution in a physiologically more relevant setting than previously reported, we 
revealed that there is a periodic pattern of traction at the leading and the trailing edges in 
neutrophils during chemotaxis. We also found the regulatory mechanism of traction in 
neutrophil chemotaxis in which nonmuscle myosin II and its spatially distinct, upstream 
kinases are involved. In particular, MLCK-driven contractile forces at the leading edge 
were found to be important for traction and adhesion, allowing persistent protrusion in 
neutrophil chemotaxis. Our findings have begun to shed light on the characteristics, 
mechanisms and functions of traction in neutrophil chemotaxis.        
 
Periodic, out-of-phase pattern of traction in neutrophil chemotaxis 
Our results reveal novel mechanical aspects of cell polarity and motility in 
neutrophils and are summarized in a model (Figure 5.1). We discovered a periodic 
pattern of tractions at the leading and the trailing edge in a neutrophil-like cell line and 
primary neutrophils during chemotaxis. This oscillatory pattern has not been documented 
for any biochemical or mechanical factors in neutrophils during chemotaxis. What might 
be the function of the periodic tractions? We speculate that the oscillations at the front of 
the cell may be linked to the cycle of leading edge extension and adhesion. In this 
scenario, extension of the pseudopod occurs with minimal contact with the ECM 
substrate and is thus associated with weak tractions. In contrast, strong tractions could 
result from establishment and stabilization of leading edge attachment. In addition, the 
traction oscillations at the cell’s rear may correspond to periodic contractions that enable 
the cell to pull the trailing edge forward. A future study examining the link between the 
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periodic oscillation of traction and the distinct steps in cell migration cycle (i.e., 
protrusion, adhesion, contraction and tail retraction) during neutrophil chemotaxis is 
required to test the validity of such hypothesis.    
Interestingly, in addition to the periodic patterns, we found that the traction 
oscillations at the front and the back are out of phase, with the tractions at the front 
leading those at the back, thus pointing to a timing mechanism that allows neutrophils to 
coordinate leading edge adhesion and trailing edge de-adhesion to ensure persistent 
movements. We can only speculate about the molecular mechanism that gives rise to the 
temporal shift. Chemoattractant-induced activation of MLCK may precede that of p160-
ROCK (Figure 5.1), which could cause the delay in myosin II activation and myosin II 
contractility at the rear. This possibility could be tested by examining the temporal 
dynamics of MLCK, p160-ROCK and Rho activation in response to attractants, probably 
with high-sensitivity live cell biosensors for MLCK and p160-ROCK activities. Notably, 
our findings contrasted an earlier study in which traction stresses were detected mostly in 
the uropod of neutrophils migrating on a stiffer substrate (9 kPa) (Smith et al., 2007). The 
differential patterns of tractions observed may be attributed to the differences in substrate 
stiffness, temporal resolutions of the studies and/or other undefined factors.  
 
On the regulatory mechanisms of traction involving myosin II and its 
upstream kinases during neutrophil chemotaxis 
How are tractions regulated in neutrophils during chemotaxis? Our current 
findings suggest that tractions at the leading and the trailing edge in neutrophils require 
myosin II activation. Inhibition of myosin II impairs the level and the periodicity of 
tractions. Our results suggest that the recruitment of MLCK to the neutrophil’s leading 
edge activates MRLC and myosin II contractility, allowing cells to exert tractions on the 
ECM substrate, enhance integrin activity and stabilize leading-edge adhesion (Figure 5.1). 
The spatially controlled activation of Rho, p160-ROCK and subsequent myosin II 
activation (Xu et al., 2003) leads to contraction of actin-myosin complexes at the trailing 
edge, causing it to de-adhere (Figure 5.1). At least three possibilities, alone or in 
combination, could account for the periodic pattern of tractions. It might be that myosin 
II is activated periodically during chemotaxis. Alternatively, the strength of cell-substrate 
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adhesion might be temporally regulated, leading to alternation of weak and strong local 
tractions during neutrophil migration. Third, there might be myosin II-independent 
mechanism(s) that also contribute to the development and periodicity of tractions. In our 
experiments, there are significant amounts of tractions remaining after inhibition of total 
or localization-specific myosin II activities. Our results are in keeping with a recent 
report demonstrating that inhibition of myosin II functions fails to abolish tractions in 
Dictyostelium cells during chemotaxis (Meili et al., 2010). One group of putative 
candidates that might control tractions in neutrophils are plasma membrane-anchored 
myosin class I molecules, which reportedly could generate membrane tension by pulling 
on F-actin coupled to ECM via integrins (Nambiar et al., 2009). Other candidates include 
force-bearing cytoskeletal molecules such as microtubules and intermediate filaments 
that can transmit force to actin through various inter-cytoskeletal linkage (Rodriguez et 
al., 2003; Wang et al., 2009).  More complete understanding of the detailed mechanisms 
governing the periodic and out-of-phase behavior of tractions awaits future experiments. 
In addition, future experiments should investigate whether the observed spatiotemporal 
dynamics of tractions and their regulatory patterns can be extended to neutrophils under 
other extracellular settings (e.g., on ECM substrates for 2-integrin) and to other 
amoeboid cells.  
 
MLCK-mediated actomyosin contractility in the regulation of traction, 
integrin activation and adhesion in neutrophil chemotaxis   
In slow migrating cells such as fibroblasts, MLCK is mainly found in stress fibers 
(Katoh et al., 2001). Distribution of MLCK in neutrophils differs from this pattern. As in 
neutrophils, MLCK and ROCK in fibroblasts play distinct roles in regulating membrane 
protrusions and adhesion dynamics during cell migration (Totsukawa et al., 2004a). 
MLCK inhibition blocks MRLC phosphorylation at the cell periphery, but not in the 
center and prevents zyxin-containing adhesions at the periphery. These cells generate 
membrane protrusions all around the cell, turn more frequently, and migrate less 
effectively. In contrast, ROCK inhibition blocks MRLC phosphorylation in the center 
and prevents formation of focal adhesions. These cells move faster and straighter. Thus, 
although the MRLC activation in fibroblasts is spatially controlled by MLCK and ROCK, 
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their distribution and function in the control of cell migration seem to differ from those in 
neutrophils. 
How might MLCK inhibition (or depletion) at the leading edge affect tractions at 
both edges in neutrophils during chemotaxis? It is well accepted that organization of actin 
cytoskeleton in cells is heavily dependent on mechanical force. Increasing tension in the 
actin network leads to formation of actin bundles, which can be prevented by the 
inhibition of myosin activity (Amano et al., 1997; Sims et al., 1992). More recently, it 
was demonstrated that nonmuscle myosin II is required not only to establish but also to 
maintain integrity of the actomyosin network (Cai et al.). Based on these results, we 
speculate that the global effect of MLCK inhibition on tractions in neutrophils might be 
linked to its ability to regulate myosin II-dependent contractility. In this scenario, 
depletion or inhibition of MLCK impairs myosin II contractility at the leading edge and 
in turn disrupts the structure and organization of the actin cytoskeleton (Figure 5.1), as 
shown by experiments with live and fixed neutrophils. Myosin II might crosslink actin 
filaments into a coherent mechanical network that allows transmission of force from one 
side of the cell to the other (Sims et al., 1992). In neutrophils, the actin cytoskeletal 
network appears highly organized and interconnected (Movie S4), and thus might provide 
a structural framework for the putative mechanotransduction activity. Alternatively, force 
might be transmitted through connections among different types of cytoskeletons, as 
shown in other cells and organisms (Petrasek and Schwarzerova, 2009; Rodriguez et al., 
2003). Thus, MLCK inhibition at the leading edge could also affect the structure and 
organization of the actin cytoskeleton at the trailing edge of the cells, leading to a 
decrease in tractions at the rear. Similarly, this model (Figure 5.1) also explains the 
decreased tractions at both edges of the cells after p160-ROCK is inhibited. 
However, it is of note that the proposed model (Figure 5.1) cannot explain how 
p160-ROCK-inhibited neutrophils retain periodicity of tractions at both edges on stiffer 
substrate (100 kPa), while accounting for the reduction in traction level at both edges in 
the same cells. It might be that a higher-stiffness substrate helps to better support and 
maintain cytoskeletal organization and integrity in neutrophils, rendering cells less 
susceptible to local inhibition of myosin II. Indeed, the degree of integrity and 
organization of actin cytoskeleton is closely related to mechanical properties of 
 70
extracellular environment. More bundled, ordered stress fiber formation is observed in 
fibroblasts on stiffer matrix (Yeung et al., 2005). Furthermore, p160-ROCK, unlike 
MLCK, is not required for leading edge activities and thus, when inhibited, exerts little 
effects on leading edge protrusion and stability. As such, the remaining myosin II activity 
after p160-ROCK inhibition could still enable the cells to maintain the pattern of 
tractions on both the leading and the trailing edge. An alternative possibility is that the 
putative myosin II-independent mechanism(s), as discussed earlier, might be actively 
engaged to support the periodic pattern of tractions at the back of the cells under these 
conditions.  
How does MLCK control integrin activation in neutrophils? Our results, as well 
as those from others, have begun to point to a role for myosin II-dependent mechanical 
tension. Friedland et al. (Friedland et al., 2009) reported that integrin can switch 
between relaxed and tensioned states in response to myosin II–generated cytoskeletal 
force. The resulting force combines with cell-substrate adhesion to generate tension that 
activates the integrin molecule mechanically. Our results also suggest that myosin II-
dependent cellular contraction mediates MLCK’s effect on adhesion and integrin 
activation. MLCK inhibition fails to prevent integrin activation in neutrophils in 
suspension, implying the role of tractions in the regulation of integrin activity. We 
suspect that the tension applied to specific molecules (e.g., talin (Tadokoro et al., 2003) 
or vinculin (Critchley and Gingras, 2008)) that control integrin activity might change 
their conformations to “active,” as in the “conformational switch” model (Geiger and 
Bershadsky, 2001) proposed to explain the maturation of focal adhesions by internal 
actin-myosin contraction in fibroblasts. In support of this notion, application of 
physiologically relevant forces causes stretching of single talin rods that expose cryptic 
binding sites for vinculin (del Rio et al., 2009). Thus, the documented protein stretching 
may represent a more general mechanism for force transduction in a variety of signaling 
events, including integrin activation. 
We conclude that periodic, out-of-phase traction generation at the leading and the 
trailing edges of neutrophils during chemotaxis may be an important mechanism for 
ensuring persistent movement by coordinating activities at both edges of cells. Future 
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experiments are necessary to elucidate the molecular mechanisms governing the 
generation, periodicity, and timing of traction in neutrophil chemotaxis.        
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Figures 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Integration of mechanical and biochemical signals to regulate leading 
edge adhesion and trailing edge de-adhesion: A model. 
The model is proposed based on analyses of cell migration on the 3.5 kPa substrate. See 
text for details. GPCR: G protein-coupled receptor 
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APPENDIX:  
TEXT FOR SUPPLEMENTARY MOVIES 
 
 
Supplementary Movie S1 (traction map) shows the responses of control dHL-60 cells to a 
point source of fMLP. Some of the time points are shown in Figure 2.1A in the text. The 
total time is 290 sec.  
 
Supplementary Movie S2 (fluorescence channel) and Supplementary Movie S3 (DIC 
channel) show the responses of dHL-60 cells expressing mCherry-tagged myosin IIA to a 
point source of fMLP. Some of the time points are shown in Figure 3.1B in the text. 
 
Supplementary Movie S4 (green fluorescence channel) and Supplementary Movies S5 
(red fluorescence channel) show 3 dimensional views of a polarized dHL-60 cell stained 
with Alexa fluor 488 phalloidin to localize F-actin (green; Movie S4) and a specific 
antibody against myosin IIA (red; Movie S5). The schematic views are shown in Figure 
3.1D.  
 
Supplementary Movie S6 (DIC channel) shows the responses of control dHL-60 cells to a 
point source of fMLP. Some of the time points are shown in Figure 3.4A in the text. 
 
Supplementary Movie S7 (DIC channel) shows the responses of blebbistatin-treated 
dHL-60 cells to a point source of fMLP. Some of the time points are shown in Figure 
3.4A in the text. 
 
Supplementary Movie S8 (DIC channel) shows the responses of myosin IIA-depleted 
dHL-60 cells to a point source of fMLP. Some of the time points are shown in Figure 
3.4A in the text. 
 
Supplementary Movie S9 (DIC channel) shows the responses of Y-27632-treated dHL-60 
cells to a point source of fMLP. Some of the time points are shown in Figure 3.4A in the 
text. 
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Supplementary Movie S10 (GFP channel) and Supplementary Movie S11 (DIC channel) 
show the responses of dHL-60 cells expressing sMLCK-EGFP to a uniform 
concentration of fMLP. Some of the time points are shown in Figure 4.1D in the 
Supplementary Information. 
 
Supplementary Movie S12 (traction map) shows the responses of MLCK-depleted dHL-
60 cells to a point source of fMLP. Some of the time points are shown in Figure 4.8A in 
the text. The total time is 290 sec.  
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